Spondylopathies (FG)

SPONDYLOPATHY_FG

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters None 0 out of 7 registries used, show all original rules.	0
4. Check minimum number of events None	0
5. Include endpoints M13_ANKYLOSPON M13_SACROILIITIS M13_SPONDYLINFLAMNAS	6545
6. Filter based on genotype QC (FinnGen only)	6545

Control definitions (FinnGen only)

Control exclude: RHEUMA_ENDPOINTS

Extra metadata

First used in FinnGen datafreeze: DF2

NAME	SPONDYLOPATHY_FG
CONTROL_EXCLUDE	RHEUMA_ENDPOINTS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	M13_ANKYLOSPON\|M13_SACROILIITIS\|M13_SPONDYLINFLAMNAS
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Spondylopathies (FG) based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	39812	19066	20507
Only index persons	36761	18231	18530
Unadjusted period prevalence (%)
Whole population	0.56	0.55	0.57
Only index persons	0.69	0.67	0.71
Median age at first event (years)
Whole population	40.19	40.73	39.58
Only index persons	39.24	40.12	38.38

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	6545	3658	2887
Unadjusted period prevalence (%)	1.26	1.25	1.27
Median age at first event (years)	40.64	40.08	41.36

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
5924: Matched controls
59239

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

71240

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Spondylitis ankylopoietica

+∞

323.0

399

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

35.6

323.0

436

132

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

4369.3

323.0

1665

A07EC01

ATC

sulfasalazine; oral, rectal

234.1

323.0

3731

428

L88

ICPC

Rheumatoid/seropositive arthritis

199.5

323.0

997

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

22.3

323.0

1289

728

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

1063.7

323.0

1512

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

955.5

323.0

1558

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

53.2

323.0

1351

327

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

874.6

323.0

331

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

68.7

323.0

1608

320

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

65.0

323.0

873

157

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

729.3

323.0

1798

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

72.0

323.0

2268

506

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

329.8

323.0

4095

400

L04AB04

ATC

adalimumab; parenteral

86.7

323.0

894

121

P01BA02

ATC

hydroxychloroquine; oral

37.1

323.0

1033

335

L04AB06

ATC

golimumab; parenteral

237.9

323.0

461

H02AB06

ATC

prednisolone; systemic

4.5

323.0

3693

15872

L04AA13

ATC

leflunomide; oral

296.6

323.0

489

M01AH05

ATC

etoricoxib; oral

3.7

323.0

4159

23142

M13.9

ICD-10 Finland

Arthritis, unspecified

26.6

323.0

895

394

M01AH01

ATC

celecoxib; oral (coxibs)

4.8

323.0

1563

4105

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

181.3

323.0

984

M17.1

ICD-10 Finland

Other primary gonarthrosis

11.6

323.0

727

708

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

273.8

323.0

360

L04AB01

ATC

etanercept; parenteral

988.2

323.0

699

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

5.9

323.0

1068

2116

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

+∞

323.0

473

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

377.8

323.0

554

M01AC06

ATC

meloxicam; systemic, rectal

3.3

323.0

2684

11772

M45

ICD-10 Finland

Ankylosing spondylitis

3765.4

323.0

3589

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

3.3

318.8

2037

8016

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

56.3

310.2

370

N02AX02

ATC

tramadol; systemic, rectal

2.9

306.2

2737

13492

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

10.2

305.7

636

687

S01BA04

ATC

prednisolone; ophthalmic (corticosteroids, plain)

17.4

299.5

487

304

M07.3*L40.5

ICD-10 Finland

Other psoriatic arthropathies

216.5

299.1

308

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.9

296.3

2712

13483

M25.5

ICD-10 Finland

Pain in joint

2.9

249.2

1921

8326

M16.1

ICD-10 Finland

Other primary coxarthrosis

22.0

246.5

368

178

H20.1

ICD-10 Finland

Chronic iridocyclitis

27.2

239.4

335

130

S01CA02

ATC

prednisolone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

26.2

236.9

335

135

A02BC02

ATC

pantoprazole; systemic

2.5

235.9

3858

25384

H22.1*M45

ICD-10 Finland

Iridocyclitis in ankylosing spondylitis

2166.9

227.4

219

M54.9

ICD-10 Finland

Dorsalgia, unspecified

4.0

227.3

1017

2886

M46.8

ICD-10 Finland

Other specified inflammatory spondylopathies

1124.7

223.2

217

M02.9

ICD-10 Finland

Reactive arthropathy, unspecified

79.8

222.6

252

M54.5

ICD-10 Finland

Low back pain

2.5

213.7

2273

11694

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

6.1

209.2

617

1116

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

58.3

207.5

246

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.8

205.9

753

1745

S01FA04

ATC

cyclopentolate; ophthalmic

22.5

204.1

302

141

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

2.3

200.1

2887

17196

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

81.1

200.1

226

NF1AA

NOMESCO Finland

Hip X-ray examination

8.1

197.0

466

615

L04AB05

ATC

certolizumab pegol; parenteral

+∞

194.8

186

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

8.6

191.8

437

542

H02AB07

ATC

prednisone; oral

3.5

191.5

1043

3448

L04AC10

ATC

secukinumab; parenteral

138.6

188.6

201

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

28.9

185.5

255

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.5

185.2

715

1742

M01CB01

ATC

sodium aurothiomalate; parenteral

915.9

182.3

178

WZA10

NOMESCO Finland

Long statement of health and health related matters

20.0

178.9

275

144

M01AH02

ATC

rofecoxib; oral

3.7

172.5

855

2604

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

7.1

168.1

434

650

M01AE02

ATC

naproxen; oral, rectal

2.1

163.2

3496

23996

L04AA11

ATC

[U] etanercept; parenteral

1665.1

162.1

157

N03AX16

ATC

pregabalin; oral

2.6

160.7

1425

6424

M79.0

ICD-10 Finland

Rheumatism, unspecified

9.6

159.0

338

370

TNG10

NOMESCO Finland

Puncture of knee

210.7

158.8

164

UJF32

NOMESCO Finland

Coloscopy

2.4

152.7

1551

7497

L40.5

ICD-10 Finland

Arthropathic psoriasis

41.8

150.9

190

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

4.1

146.9

619

1624

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

10.0

146.3

304

319

TNX00

NOMESCO Finland

Puncture and needle biopsy of soft tissue, unspecified region

14.3

144.6

252

183

M03BX02

ATC

tizanidine; oral

2.0

144.4

3818

27874

M01AX17

ATC

nimesulide; oral

2.5

141.6

1383

6508

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

3.9

139.7

634

1774

L04AX01

ATC

azathioprine; systemic

5.5

138.5

439

854

N02AJ06

ATC

codeine and paracetamol; systemic

2.1

138.1

2209

13084

N02BE01

ATC

paracetamol; systemic, rectal

2.3

137.3

4912

40243

M07.3

ICD-10 Finland

Other psoriatic arthropathies

1367.3

137.0

133

S01FA02

ATC

scopolamine; ophthalmic

19.5

135.1

209

111

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

342.3

134.2

135

NH3EA

NOMESCO Finland

Feet X-ray examination with load

18.7

133.9

210

116

M01AB55

ATC

diclofenac, combinations; oral

4.8

133.4

478

1065

NA6AA

NOMESCO Finland

Sacro-iliac joint X-ray examination

68.2

132.4

153

M01AE03

ATC

ketoprofen; systemic, rectal

2.1

130.1

2163

12935

A02BC03

ATC

lansoprazole; oral

2.2

129.1

1685

9072

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

9.2

129.0

280

317

M35.7

ICD-10 Finland

Hypermobility syndrome

38.5

128.9

165

M01AB01

ATC

indometacin; systemic, rectal

4.3

128.8

521

1309

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.0

128.3

2188

13197

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

18.2

128.3

203

115

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

17.7

127.6

204

119

TNH11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in ankle joint or foot joint

116.8

126.6

137

M01AB05

ATC

diclofenac; systemic, rectal

2.0

126.4

3888

29271

M01AX01

ATC

nabumetone; oral

5.8

124.6

376

688

NA1EA

NOMESCO Finland

Cervical spine X-ray examination with flexion

17.3

124.2

200

119

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

20.5

123.2

187

TNG11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in knee

1192.1

120.3

117

N03AX12

ATC

gabapentin; oral

2.7

118.6

914

3724

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

6.4

117.3

325

533

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.8

116.3

543

1547

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

115.0

2361

15121

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

69.8

113.0

130

TND11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in joint, wrist or hand

73.0

112.9

129

M79.7

ICD-10 Finland

Fibromyalgia

8.5

109.6

249

304

M06.8

ICD-10 Finland

Other specified rheumatoid arthritis

363.8

107.6

108

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

3.9

107.3

472

1275

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

32.3

106.7

142

H20.9

ICD-10 Finland

Iridocyclitis, unspecified

13.1

105.9

191

150

H02AB04

ATC

methylprednisolone; systemic

2.6

105.5

895

3833

XX9XE

NOMESCO Finland

Other ultrasound examination

39.2

105.2

134

M01CB03

ATC

auranofin; oral

273.2

105.2

107

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

4.1

103.2

433

1120

ZX140

NOMESCO Finland

Intra articular

49.0

102.7

125

L03

ICPC

Low back symptom/complaint

2.1

102.0

1403

7594

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.0

101.8

1542

8687

M03BC01

ATC

orphenadrine (citrate); systemic

2.1

101.4

1525

8566

NG1DA

NOMESCO Finland

X-ray of knees

26.4

101.3

142

M05BA04

ATC

alendronic acid; oral

4.1

97.3

409

1058

L04AA17

ATC

[U] adalimumab; parenteral

+∞

96.1

NE1AA

NOMESCO Finland

Pelvis X-ray examination

5.1

95.4

319

655

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.0

95.4

1423

7929

NF1DA

NOMESCO Finland

X-ray of hips

24.1

95.3

137

R4110

NOMESCO Finland

Physiotherapy

2.0

94.6

1447

8144

A02BC05

ATC

esomeprazole; systemic

1.8

94.4

2190

14356

M13.0

ICD-10 Finland

Polyarthritis, unspecified

40.5

94.2

119

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

+∞

94.0

L04AA01

ATC

[U] ciclosporin; systemic

13.2

92.5

166

129

A07EC02

ATC

mesalazine; oral, rectal

3.4

90.6

474

1472

ZX120

NOMESCO Finland

Intravenous

2.8

89.2

618

2333

N06AA09

ATC

amitriptyline; systemic

2.9

88.0

585

2146

NG1AE

NOMESCO Finland

Knee joint ultrasound exmination

36.5

86.0

111

M54.4

ICD-10 Finland

Lumbago with sciatica

2.2

85.5

969

4766

M79.6

ICD-10 Finland

Pain in limb

1.8

85.3

1830

11580

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

2.3

85.0

864

4033

H04.10

ICD-10 Finland

Dry eye syndrome

2.8

83.3

605

2346

M70.6

ICD-10 Finland

Trochanteric bursitis

2.8

82.9

586

2236

Z01.0

ICD-10 Finland

Examination of eyes and vision

2.2

82.7

942

4638

A02BC01

ATC

omeprazole; systemic

1.9

81.5

1428

8387

7140A

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SEROPOSITIVA]

+∞

81.4

NK5AT

NOMESCO Finland

Joint injection with ultrasound guidance not elsewhere classified

32.3

81.4

108

M46.0

ICD-10 Finland

Spinal enthesopathy

78.0

81.3

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

3.7

80.9

376

1059

B01AB05

ATC

enoxaparin; parenteral

2.0

80.8

1351

7791

NA1BA

NOMESCO Finland

Cervical spine extensive X-ray examination without contrast

16.8

80.2

130

N06AX21

ATC

duloxetine; oral

2.5

78.4

668

2834

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

3.7

78.3

368

1046

36400

ICD-8 Finland

Iritis, Iridocyclitis acuta

28.6

78.2

107

NH1AE

NOMESCO Finland

Ankle joint ultrasound examination

52.4

77.5

M13.8

ICD-10 Finland

Other specified arthritis

25.8

77.5

109

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.3

76.2

770

3568

K50.8

ICD-10 Finland

Other Crohn disease

6.4

75.4

207

334

J01DB01

ATC

cefalexin; oral

1.8

74.9

4646

39738

M48.0

ICD-10 Finland

Spinal stenosis

2.8

74.9

527

1998

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

6.1

74.8

213

361

71239

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides NUD

67.0

74.5

M35.0

ICD-10 Finland

Sicca syndrome [Sjögren]

32.8

73.5

UJF30

NOMESCO Finland

Ileoscopy through colon

2.6

73.4

594

2446

M47.82

ICD-10 Finland

Other spondylosis, cervical region

4.8

72.6

254

547

M08.4

ICD-10 Finland

Pauciarticular juvenile arthritis

+∞

71.0

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

5.0

70.2

236

487

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

69.5

1157

6612

M35.9

ICD-10 Finland

Systemic involvement of connective tissue, unspecified

108.5

69.0

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

1.7

68.9

1980

13517

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

67.8

NGF15

NOMESCO Finland

Total synovectomy of knee, arthroscopic

14.9

67.2

114

NB1AE

NOMESCO Finland

Shoulder ultrasound examination

7.8

67.1

159

208

M54.6

ICD-10 Finland

Pain in thoracic spine

2.8

66.6

468

1769

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.2

66.6

371

1201

4AB02

NOMESCO Finland

21.6

66.2

L15

ICPC

Knee symptom/complaint

2.1

66.1

840

4303

K50.9

ICD-10 Finland

Crohn disease, unspecified

6.5

64.6

174

274

L13

ICPC

Hip symptom/complaint

2.4

64.4

601

2664

NE1CG

NOMESCO Finland

Pelvic, hip and femur extensive MRI examination with high intensity magnet

7.3

64.4

160

225

J01AA02

ATC

doxycycline; systemic

1.6

64.2

4250

35932

M02AA07

ATC

piroxicam; topical

1.7

64.0

1737

11605

WX320

NOMESCO Finland

Spinalanesthesy

2.0

63.9

948

5164

N02AA05

ATC

oxycodone; systemic

2.4

63.6

608

2726

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.7

63.3

1658

10953

SPAT1153

SPAT

Removal of sutures

1.7

63.3

1507

9675

ND2BA

NOMESCO Finland

Hand and fingers extensive X-ray examination

6.7

63.1

166

253

WX111

NOMESCO Finland

Local infiltration anesthesia

99.7

62.9

M05

ICD-10 Finland

Seropositive rheumatoid arthritis

215.6

62.2

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

4.0

62.1

264

687

A07EA06

ATC

budesonide; oral, local oral

3.7

61.6

281

777

TPH04

NOMESCO Finland

Cathetrisation of vein

1.9

61.2

1050

6035

K50.0

ICD-10 Finland

Crohn disease of small intestine

5.7

61.0

182

327

J01MA02

ATC

ciprofloxacin; systemic

1.6

61.0

1957

13662

M35.3

ICD-10 Finland

Polymyalgia rheumatica

8.0

61.0

142

181

J01CA04

ATC

amoxicillin; systemic

1.7

60.8

4617

40136

212

Kela drug reimbursment

Gout

+∞

60.5

J01FF01

ATC

clindamycin; systemic

1.7

60.2

1420

9063

M01AC01

ATC

piroxicam; systemic, rectal

2.2

60.1

695

3404

M06

ICD-10 Finland

Other rheumatoid arthritis

205.4

59.1

L40.0

ICD-10 Finland

Psoriasis vulgaris

3.6

59.1

283

815

R06.0

ICD-10 Finland

Dyspnoea

1.8

59.1

1146

6862

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

127.3

58.9

NFB40

NOMESCO Finland

Primary total prosthetic replacement of hip joint using hybrid technique

25.6

57.7

H57.1

ICD-10 Finland

Ocular pain

3.9

57.4

250

665

SPAT1249

SPAT

Treatment-related counselling outside office

1.6

57.2

2103

15150

M01AB08

ATC

etodolac; oral

2.7

57.1

430

1690

SAA02

NOMESCO Finland

Basic examination of mouth

1.6

57.0

3648

30039

S18

ICPC

Laceration/cut

1.6

56.7

1953

13826

M13.1

ICD-10 Finland

Monoarthritis, not elsewhere classified

21.3

56.6

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

3.7

56.3

256

706

H22.1

ICD-10 Finland

Iridocyclitis in other diseases classified elsewhere

289.4

56.3

M03BC51

ATC

orphenadrine, combinations; systemic

1.7

56.3

1547

10294

H15.1

ICD-10 Finland

Episcleritis

6.3

55.8

154

251

3640A

ICD-9 Finland

Disorders of iris and ciliary body, Acute and subacute iridocyclitis

59.7

55.5

A02BA02

ATC

ranitidine; systemic

1.9

55.5

933

5304

L28

ICPC

Limited function/disability (L)

2.2

54.9

612

2943

M01AX05

ATC

glucosamine; oral

2.2

54.7

611

2943

71238

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Arthritis rheumatoides alia definita

58.8

54.5

NF2AT

NOMESCO Finland

Injection to hip joint with ultrasound guidance

38.8

54.4

7140B

ICD-9 Finland

Rheumatoid arthritis and other inflammatory polyarthropathies, Rheumatoid arthritis[ARTHRITIS RHEUMATOIDES SERONEGATIVA]

+∞

54.2

M07.2*L40.5

ICD-10 Finland

Psoriatic spondylitis

+∞

54.2

M54.2

ICD-10 Finland

Cervicalgia

2.6

54.2

425

1707

M17.5

ICD-10 Finland

Other secondary gonarthrosis

40.5

54.1

NH3BA

NOMESCO Finland

Foot and toes extensive X-ray examination

4.4

53.4

202

471

M08.0

ICD-10 Finland

Juvenile rheumatoid arthritis

+∞

53.2

R03AC02

ATC

salbutamol; inhalant

1.5

53.1

2798

21856

M16.7

ICD-10 Finland

Other secondary coxarthrosis

141.3

52.9

E0000UV

ATC

1.6

52.6

2073

15104

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.6

52.5

1578

10725

NA1CG

NOMESCO Finland

Cervical spine extensive MRI examination with high intensity magnet

5.5

52.0

158

291

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.6

51.8

1549

10506

L90

ICPC

Osteoarthrosis of knee

5.1

51.4

167

332

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.6

51.4

2033

14808

K02.1

ICD-10 Finland

Caries of dentine

1.5

51.4

3226

26133

M02.1

ICD-10 Finland

Postdysenteric arthropathy

262.8

51.2

M10.9

ICD-10 Finland

Gout, unspecified

4.3

51.1

197

468

M02.8

ICD-10 Finland

Other reactive arthropathies

38.1

50.4

72699

ICD-8 Finland

Affection of sacro-iliac joint

+∞

50.1

WZC30

NOMESCO Finland

Teaching

2.0

49.6

691

3646

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.7

49.5

1095

6794

J01FA06

ATC

roxithromycin; oral

1.5

49.2

2085

15392

7209X

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Unspecified inflammatory spondylopathy

+∞

49.0

P01AB01

ATC

metronidazole; oral, rectal

1.5

48.3

2066

15270

SPAT1263

SPAT

Sampling

1.5

48.2

2191

16421

H02AB08

ATC

triamcinolone; systemic

56.5

47.5

N02AC04

ATC

dextropropoxyphene; oral

4.1

47.4

194

488

D07AC01

ATC

betamethasone; topical

1.6

47.3

1684

11892

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

2.8

47.3

326

1213

L04AD01

ATC

ciclosporin; systemic

5.6

47.0

142

260

ZXA00

NOMESCO Finland

Right side

1.7

46.8

1132

7197

L99

ICPC

Musculoskeletal disease other

6.0

46.6

133

227

WX002

NOMESCO Finland

Sedation and analgesia

1.8

46.6

858

5006

R50.9

ICD-10 Finland

Fever, unspecified

1.9

46.3

734

4063

J01FA10

ATC

azithromycin; systemic

1.5

46.2

3216

26353

SAA01

NOMESCO Finland

Simple examination of mouth

1.5

46.0

3939

33715

O99.89

ICD-10 Finland

Other specified diseases and conditions complicating pregnancy, childbirth and the puerperium

4.7

45.9

163

357

L02

ICPC

Back symptom/complaint

2.2

45.9

515

2476

M08.3

ICD-10 Finland

Juvenile polyarthritis (seronegative)

+∞

45.9

M08.1

ICD-10 Finland

Juvenile ankylosing spondylitis

+∞

45.9

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

1.9

45.9

712

3910

H20

ICD-10 Finland

Iridocyclitis

15.0

45.8

M54

ICD-10 Finland

Dorsalgia

2.0

45.8

640

3378

M54.8

ICD-10 Finland

Other dorsalgia

3.2

45.7

259

845

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

1.8

45.4

914

5489

TNB11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in shoulder joint

36.6

45.3

K07.60

ICD-10 Finland

Snapping jaw

2.8

45.2

317

1191

SPAT1202

SPAT

Intra-articular injection

5.3

45.1

141

269

K51.5

ICD-10 Finland

Left sided colitis

3.4

45.0

229

692

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

+∞

44.8

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.7

44.8

1212

7943

Z50.1

ICD-10 Finland

Other physical therapy

2.9

44.7

281

987

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.0

44.6

643

3433

ZXA05

NOMESCO Finland

Left side

1.7

44.5

1062

6717

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

2.7

44.2

323

1242

M01AE52

ATC

naproxen and esomeprazole; oral

3.7

44.1

200

551

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

2.4

43.9

411

1813

M04AA01

ATC

allopurinol; systemic

2.3

43.8

427

1922

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.5

43.5

2889

23317

XCW99

NOMESCO Finland

Other investigative procedure of eye

2.1

43.4

511

2509

A01

ICPC

Pain general/multiple sites

2.5

43.3

368

1543

SPAT1301

SPAT

No procedures

1.6

43.3

1516

10617

R51.80

ICD-10 Finland

Headache

1.8

42.9

807

4732

7202A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Sacro-iliitis, not elsewhere classified

+∞

42.7

NA2CG

NOMESCO Finland

Thoracal spine extensive MRI examination with high intensity magnet

8.3

42.6

117

M02AA10

ATC

ketoprofen; topical

1.9

42.5

739

4216

K50.1

ICD-10 Finland

Crohn disease of large intestine

5.3

42.1

133

257

D07XC01

ATC

betamethasone, combinations; topical

2.0

42.0

595

3151

L17

ICPC

Foot/toe symptom/complaint

1.7

42.0

1133

7408

B01AF01

ATC

rivaroxaban; oral

2.5

41.9

340

1388

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.5

41.9

3177

26248

M01AH03

ATC

valdecoxib; oral

2.6

41.5

331

1340

L89

ICPC

Osteoarthrosis of hip

9.1

41.2

M19.0

ICD-10 Finland

Primary arthrosis of other joints

2.3

41.0

388

1720

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

5.1

40.8

132

262

71200

ICD-8 Finland

Rheumatoid arthritis and allied conditions, Juvenile rheumatoid arthritis

+∞

40.7

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.7

40.5

863

5260

J01DA01

ATC

[U] cefalexin; systemic

1.4

40.4

3336

27932

RK220

NOMESCO Finland

27.7

40.3

NFC20

NOMESCO Finland

Secondary implantation of hip prosthesis

59.2

40.2

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.4

40.2

2956

24185

WX110

NOMESCO Finland

Local anesthesy

1.5

40.2

3761

32265

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

3.5

39.8

196

578

L84

ICPC

Back syndrome without radiat pain

2.8

39.7

262

950

L04AA24

ATC

abatacept; parenteral

+∞

39.6

R42

ICD-10 Finland

Dizziness and giddiness

1.7

39.5

936

5888

TNF11

NOMESCO Finland

Injection of diagnostic or therapeutic substance in hip joint

390.0

39.1

R07.4

ICD-10 Finland

Chest pain, unspecified

1.6

39.0

1171

7853

M06.4

ICD-10 Finland

Inflammatory polyarthropathy

32.1

38.8

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

2.4

38.4

337

1437

M47.9

ICD-10 Finland

Spondylosis, unspecified

3.8

38.1

167

448

WZA90

NOMESCO Finland

Other doctors statement

1.6

38.0

1153

7752

A06AC01

ATC

ispaghula (psylla seeds); oral

1.6

37.9

1069

7048

NG1EA

NOMESCO Finland

Knee X-ray examination with wrench

20.9

37.8

D05AX52

ATC

calcipotriol, combinations; topical

2.6

37.8

295

1180

M15.0

ICD-10 Finland

Primary generalized (osteo)arthrosis

5.3

37.4

118

228

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

3.7

37.3

170

471

M01AE01

ATC

ibuprofen; systemic, rectal

1.6

37.3

5111

47105

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

37.1

2050

15769

SPAT1325

SPAT

Vaccination

1.5

37.1

1528

11040

M02.3

ICD-10 Finland

Reiter disease

369.6

37.0

NA6BM

NOMESCO Finland

Sacro-iliac joint MRI examination with 3 Tesla magnet

100.7

36.7

NDG30

NOMESCO Finland

Fusion of wrist, total

32.2

36.6

B01AX06

ATC

[U] rivaroxaban; oral

18.8

36.5

4AA12

NOMESCO Finland

14.7

36.2

NF1BA

NOMESCO Finland

Hip extensive X-ray examination

6.5

36.0

147

NDL52

NOMESCO Finland

Tenosynovectomy of hand

15.7

36.0

S01BA07

ATC

fluorometholone; ophthalmic (corticosteroids, plain)

4.3

35.7

138

330

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.4

35.5

2442

19544

S01BC03

ATC

diclofenac; ophthalmic

3.6

35.2

163

458

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

5.2

35.2

111

215

J45.9

ICD-10 Finland

Asthma, unspecified

1.7

35.2

806

5002

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

2.9

34.9

218

763

M09AX01

ATC

hyaluronic acid; parenteral

4.7

34.6

121

262

UJF92

NOMESCO Finland

Capsular endoscopy

4.0

34.5

144

370

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.3

34.5

338

1522

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.1

34.3

421

2098

C03CA01

ATC

furosemide; systemic

1.6

34.3

921

5975

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.7

34.0

814

5111

M32.9

ICD-10 Finland

Systemic lupus erythematosus, unspecified

176.0

33.7

L20

ICPC

Joint symptom/complaint NOS

3.3

33.6

174

534

M17.3

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

454

392

12.37

307.65

1.1

iu/ml

2.1

2.7

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

369

100

39.04

307.65

1.7

2.7

mg/l

9.2

9.8

0.44

289

(3021440) Promyelocytes/100 leukocytes in Blood

1128

3298

3.92

307.65

5.2

3.9

0.1

0.2

2.15

234

904

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

312

41.95

307.65

1.6

2.0

au/ml

171.8

108.9

—

(3019069) Monocytes/100 leukocytes in Blood

4551

22263

4.43

307.65

11.6

5.3

8.7

8.4

7.94

4415

20874

(3021788) Differential panel - Synovial fluid

374

173

22.87

307.65

1.8

1.2

—

(3000475) Leukocytes [#/volume] in Synovial fluid

447

270

17.70

307.65

2.0

1.3

e6/l

8735.9

21021.7

1.46

343

191

(3006504) Eosinophils/100 leukocytes in Blood

4533

22126

4.41

307.65

11.2

5.1

2.7

2.9

5.73

4396

20580

(3022096) Basophils/100 leukocytes in Blood

4467

21344

4.44

307.65

11.3

5.1

0.7

11.21

4333

19883

(3018010) Neutrophils/100 leukocytes in Blood

4552

22757

4.28

307.65

10.8

4.9

55.7

56.7

6.87

4412

21297

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

5662

37035

4.92

307.65

10.9

6.8

u/l

73.9

76.2

4.48

5522

34838

(3002030) Lymphocytes/100 leukocytes in Blood

4587

23154

4.28

307.65

11.3

5.1

30.1

28.8

15.57

4444

21589

(3037467) Urinalysis macro (dipstick) panel - Urine

5125

33295

3.49

307.65

6.4

3.5

—

(3006315) Basophils [#/volume] in Blood

5037

23499

5.96

307.65

10.8

4.9

e9/l

0.0

5.32

4766

20186

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

265

116

23.77

307.65

1.9

1.1

53.4

68.7

2.75

164

(42870588) Differential panel, method unspecified - Blood

3758

15072

4.51

307.65

9.9

5.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

481

348

14.84

307.65

1.6

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1098

3165

3.97

307.65

4.6

3.8

0.3

0.6

5.09

201

701

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

1230

1016

14.68

307.65

1.6

iu/ml

0.5

0.4

0.02

282

200

(3044941) Cell count panel - Synovial fluid

298

187

16.65

307.65

1.6

1.2

—

(3025159) Blasts/100 leukocytes in Blood

1088

3130

3.97

307.65

5.3

3.9

0.0

0.3

1.20

207

759

(3035350) Ketones [Presence] in Urine by Test strip

4036

23490

2.87

307.65

4.8

3.0

estimate

0.0

1.28

913

4242

(3001604) Monocytes [#/volume] in Blood

5023

23411

5.93

307.65

10.8

4.9

e9/l

0.6

1.29

4749

20123

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1728

6654

3.17

307.65

1.3

1.2

u/ml

11.7

2.8

6.92

731

2726

(3013650) Neutrophils [#/volume] in Blood by Automated count

5250

27601

5.56

307.65

13.0

8.6

e9/l

3.9

4.1

7.77

4975

23912

(3019198) Lymphocytes [#/volume] in Blood

5067

24328

5.79

307.65

10.9

4.9

e9/l

2.0

1.30

4832

21392

(3037522) Nuclear Ab [Titer] in Serum

1954

5764

4.41

307.65

1.4

1.3

titre

441.0

371.0

1.27

429

923

(3008898) HLA-B27 [Presence]

1213

1538

9.45

307.65

1.1

—

(3013115) Eosinophils [#/volume] in Blood

5100

24439

5.92

307.65

11.0

5.2

e9/l

0.2

4.92

4866

21412

(3013707) Erythrocyte sedimentation rate by Westergren method

5805

35502

6.62

307.65

9.0

2.9

mm/h

11.9

10.2

17.52

5636

32823

(3009261) Glucose [Presence] in Urine by Test strip

4074

23803

2.88

307.65

4.9

3.0

estimate

0.0

0.03

934

4225

(3017181) Myelocytes/100 leukocytes in Blood

1163

3461

3.87

307.65

5.1

3.9

0.6

0.9

3.01

247

966

(40760892) CBC W Ordered Manual Differential panel - Blood

2565

11099

3.16

307.65

7.0

3.7

—

(3021601) Nitrite [Presence] in Urine by Test strip

4047

23550

2.88

307.65

6.2

4.1

estimate

0.0

0.23

964

4367

(3030905) Polymorphonuclear cells [#/volume] in Blood

479

767

6.66

287.90

3.8

3.3

e9/l

4.0

4.1

0.59

479

767

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

481

794

6.46

280.52

3.9

3.6

55.8

57.2

1.41

481

794

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

1722

7223

2.88

278.38

1.3

1.2

iu/ml

29.2

18.1

2.09

560

2038

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

212

111

19.70

272.72

1.7

1.1

37.3

20.6

4.36

133

(3021589) Normoblasts [#/volume] in Blood

3602

21737

2.46

271.21

14.0

8.0

e9/l

0.0

1.11

3234

17562

(3011397) Hemoglobin [Presence] in Urine by Test strip

2139

10351

2.58

257.71

4.8

3.0

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

234

171

14.15

254.02

2.8

3.3

mg/l

6.8

8.4

1.85

189

140

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

225

156

14.90

251.55

2.6

2.5

au/ml

86.2

105.0

0.21

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

3249

19244

2.37

247.77

2.7

2.1

nmol/l

75.9

75.1

0.98

3057

17585

(3017143) Hepatitis C virus Ab [Presence] in Serum

1538

6588

2.74

234.17

1.5

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

184

111

17.03

221.15

1.6

1.1

e6/l

27217.8

173380.2

1.38

125

(3029937) Albumin [Presence] in Urine by Test strip

2304

12384

2.33

212.27

5.8

3.2

estimate

0.0

2.55

940

4192

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

482

1041

4.92

209.00

1.7

1.3

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1107

4209

2.96

208.87

1.3

1.5

—

(40758558) Short blood count panel - Blood

2220

11904

2.31

204.12

8.9

6.7

—

(3048689) Calprotectin [Mass/mass] in Stool

1439

6486

2.56

193.66

3.5

2.4

ug/g

166.6

121.5

4.08

1228

5193

(3015171) Extractable nuclear Ab [Units/volume] in Serum

560

1457

4.11

191.18

1.3

1.1

u/ml

1.4

0.5

0.74

118

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

3014

18729

2.13

187.69

5.3

3.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

6202

52546

4.44

181.66

21.0

10.9

mg/l

16.3

23.2

79.89

5555

39871

(3018095) Leukocytes [#/volume] in Urine

2647

16131

2.08

168.59

3.9

3.2

e6/l

58.0

87.5

2.06

1847

11158

(40761535) Cells panel - Urine sediment

859

3265

2.88

159.58

5.0

2.9

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

120

19.70

154.93

1.5

1.1

4.4

1.9

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1758

9485

2.17

151.30

1.6

1.7

—

(3019150) Specific gravity of Urine by Refractometry

1842

10169

2.13

149.04

5.7

3.2

kg/l

1.0

1.18

251

1542

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

1902

10838

2.06

139.95

2.6

2.1

mg/l

2.9

2.8

2.13

1675

9240

(3005719) IgG [Mass/volume] in Serum or Plasma

836

3410

2.66

134.36

2.5

g/l

10.8

10.6

0.89

775

3103

(3024561) Albumin [Mass/volume] in Serum or Plasma

2893

19488

1.87

126.85

5.1

4.8

g/l

36.2

0.17

2714

18152

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

3142

21769

1.85

125.48

6.1

6.4

mmol/l

1.2

2.02

2651

18321

(3000850) Epithelial cells [#/volume] in Urine

1633

9179

2.04

122.14

2.6

2.3

e6/l

4.5

6.1

6.31

1469

7976

(3026493) Urate [Moles/volume] in Serum or Plasma

1892

11354

1.94

116.30

2.4

2.2

umol/l

3340.8

4885.3

1.07

1658

10040

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

2850

19584

1.81

113.09

5.5

5.8

mmol/l

1.2

2.93

2633

17755

(3036071) Salmonella sp Ab [Titer] in Serum

104

11.99

103.02

1.1

—

(3028026) IgM [Mass/volume] in Serum or Plasma

649

2661

2.60

101.96

1.6

1.9

g/l

1.3

0.43

617

2448

(3017732) Neutrophils [#/volume] in Blood

742

3258

2.44

100.74

3.2

2.5

e9/l

4.0

4.1

0.73

600

2694

(3041096) Erythrocytes [Presence] in Urine by Automated

2113

13642

1.81

100.21

4.1

2.7

—

(3031040) Bacteria [#/volume] in Urine by Automated count

4071

31784

1.74

97.43

4.8

3.7

e6/l

342.7

1359.2

2.06

405

(3030467) Casts [#/volume] in Urine by Automated count

1951

12406

1.82

96.62

3.2

2.8

e6/l

0.3

0.4

1.93

1570

9085

(3022948) Iron [Moles/volume] in Serum or Plasma

1228

6733

2.01

95.59

2.4

umol/l

12.7

14.1

9.05

1141

6282

(3020564) Creatinine [Moles/volume] in Serum or Plasma

6238

56534

3.20

93.53

20.6

12.6

umol/l

74.7

75.0

0.28

6238

56513

(3018418) pH of Serum or Plasma

1984

12784

1.79

93.37

3.8

4.0

7.4

0.00

409

2500

(3024263) Appearance of Synovial fluid

101

10.56

91.98

2.5

1.3

—

(36304419) Bacteria [Presence] in Urine

1915

12258

1.79

91.88

3.0

2.7

—

(3022145) Colonoscopy Study observation

1039

5444

2.08

91.25

1.5

1.3

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

3090

22795

1.67

87.32

3.2

2.7

ug/l

115.0

112.1

0.18

2912

21395

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

337

1056

3.31

86.11

1.7

1.2

g/l

0.2

0.76

318

992

(3002582) Erythrocytes [#/volume] in Urine

2046

13653

1.73

83.22

3.3

2.8

e6/l

86.3

87.3

0.01

1681

10237

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

341

1100

3.22

83.05

1.7

1.2

g/l

1.2

0.18

324

1038

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

3267

24660

1.65

82.78

5.3

6.2

umol/l

10.2

11.1

4.22

3088

23385

(3004789) Transferrin [Mass/volume] in Serum or Plasma

1115

6188

1.97

82.68

2.4

g/l

2.4

0.54

1024

5758

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

6239

57039

3.01

82.37

19.1

8.3

u/l

27.2

27.4

0.49

6149

55118

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

458

1770

2.71

80.48

1.3

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

1039

5708

1.98

79.04

2.5

21.8

24.0

5.48

887

4946

(3004588) Protein electrophoresis panel - Serum or Plasma

524

2230

2.47

75.37

1.9

2.5

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

5616

49591

1.93

74.03

15.6

10.3

ml/min/173m2

89.5

86.7

19.02

4960

40396

(3042936) Bacteria identified in Isolate by Culture

1041

5849

1.93

73.69

2.3

1.9

—

(3002385) Erythrocyte distribution width [Ratio]

5210

44979

1.78

73.68

22.2

13.7

13.5

11.04

5170

43954

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

1930

13053

1.68

72.65

2.2

2.0

u/l

151.4

237.8

5.54

1826

12328

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

343

1201

2.96

72.41

1.1

1.3

—

(3007164) IgA [Mass/volume] in Serum or Plasma

1575

10111

1.73

71.75

1.5

1.4

g/l

2.6

2.3

6.46

1080

6408

(46235355) HIV 1 and 2 tests - Meaningful Use set

1776

11834

1.69

70.31

1.8

2.0

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

2123

14872

1.63

68.84

2.8

2.6

u/l

57.3

58.0

0.19

1973

13801

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

1236

7480

1.80

68.70

2.6

2.5

e6/l

0.9

1.1

1.49

818

4045

(3023368) Bacteria identified in Blood by Culture

1694

11248

1.68

67.49

4.7

4.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

1199

7240

1.80

66.95

1.8

1.7

nmol/l

1181.0

1148.9

0.60

933

5547

(3013166) Neutrophils/100 leukocytes in Synovial fluid

14.62

64.72

1.5

1.1

37.6

62.4

3.24

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

289

992

3.00

63.14

1.4

1.1

u/ml

31.5

16.3

0.59

(3020630) Protein [Mass/volume] in Serum or Plasma

600

2922

2.16

62.52

2.0

2.8

g/l

67.8

66.7

2.80

552

2701

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

612

3030

2.12

61.07

2.0

1.6

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

394

1624

2.52

60.42

1.5

1.2

u/ml

5.7

7.6

0.17

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

263

879

3.08

60.18

1.3

1.1

u/ml

3.1

4.2

0.68

(3027945) Reticulocytes/100 erythrocytes in Blood

777

4220

1.95

59.98

2.2

2.6

1.8

1.7

1.02

687

3763

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

16.79

59.95

1.6

1.1

37.5

32.2

0.26

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

260

866

3.09

59.85

1.3

1.1

u/ml

2.1

2.3

0.12

(3032080) INR in Blood by Coagulation assay

2339

17204

1.56

59.57

7.9

7.6

inr

1.2

0.05

756

5332

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

427

1927

2.30

53.40

1.9

2.0

u/l

38.4

39.5

0.55

389

1745

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

2260

16854

1.52

52.25

3.6

3.0

ng/l

58.2

48.5

0.11

1392

9948

(3045414) Leukocytes [Presence] in Urine

425

1935

2.28

52.02

1.9

1.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

3428

27880

1.48

51.47

4.5

mmol/l

6.5

6.6

5.08

3202

25719

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

207

659

3.21

51.42

1.3

1.1

u/ml

5.6

1.7

1.13

(3019550) Sodium [Moles/volume] in Serum or Plasma

5801

53068

1.82

50.58

16.1

12.6

mmol/l

139.5

139.7

7.39

5688

51583

(3021960) Folate [Moles/volume] in Serum or Plasma

1404

9462

1.62

50.49

1.6

1.5

nmol/l

20.1

0.00

1234

8232

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

619

3321

1.95

49.08

2.5

2.3

au/ml

24.6

22.6

0.19

241

(3036670) Protein [Mass/volume] in Synovial fluid

16.50

48.70

1.3

1.0

g/l

41.1

39.0

0.15

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

2346

17828

1.49

48.61

2.0

1.8

pmol/l

93.4

96.6

2.90

1349

9441

(3023520) Reticulocytes [#/volume] in Blood

569

2976

2.00

48.53

2.3

2.7

e9/l

71.7

70.4

0.35

436

2196

(3045424) Erythrocytes [Presence] in Urine

213

714

3.05

48.48

1.5

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

1504

10389

1.58

48.47

2.8

ng/l

1031.3

1178.0

0.68

1252

8724

(3023103) Potassium [Moles/volume] in Serum or Plasma

5810

53305

1.80

48.37

16.2

12.7

mmol/l

3.9

4.0

3.06

5690

51688

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1045

6635

1.68

47.20

1.9

1.8

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

2045

15189

1.50

47.02

2.7

3.5

mmol/l

2.3

2.4

1.16

1828

13509

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

2806

22199

1.46

46.88

4.2

3.8

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

758

4409

1.81

46.63

2.3

nmol/l

339.2

381.6

7.44

704

4068

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

173

527

3.34

46.18

1.6

1.4

—

(3007566) Smooth muscle Ab [Titer] in Serum

329

1416

2.39

45.78

1.3

titre

128.1

144.7

0.10

135

(3024980) IgG subclass 4 [Mass/volume] in Serum

217

761

2.92

45.59

1.6

g/l

0.6

0.8

2.36

159

571

(40761511) CBC panel - Blood by Automated count

6028

56150

1.93

44.82

17.3

10.4

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

566

3035

1.95

44.81

1.3

au/ml

53.7

48.0

—

144

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

1524

10759

1.54

43.94

1.8

1.7

mg/l

1.0

0.72

1155

7992

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

1635

11743

1.52

43.46

1.3

u/ml

1.3

1.9

1.34

448

3297

(40761536) Microorganisms panel - Urine sediment

717

4200

1.79

42.90

4.5

3.3

—

(3034770) Mitochondria Ab [Titer] in Serum

319

1398

2.35

42.59

1.2

1.3

titre

2042.0

918.4

—

(3026782) Osmolality of Urine

1281

8758

1.58

42.40

2.9

2.5

mosm/kgh2o

540.3

553.9

1.39

1134

7424

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

304

1316

2.37

41.73

1.8

1.5

titre

275.4

196.0

0.29

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

175

575

3.10

41.25

1.4

1.1

—

(3004616) Nuclear Ab [Presence] in Serum

141

408

3.51

40.81

1.2

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

210

775

2.77

40.14

1.4

1.1

u/ml

28.1

28.6

0.02

(3007853) Bacteria identified in Skin by Aerobe culture

858

5396

1.68

39.64

2.0

1.7

—

(40768797) Stomach Pathology biopsy report

978

6381

1.63

39.07

1.2

—

(4062490)

149

462

3.28

38.69

1.4

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

1347

9499

1.53

38.28

1.7

1.6

pmol/l

42539015.1

26740579.5

0.40

1166

8074

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

754

4638

1.71

37.74

2.8

4.7

u/l

225.3

235.2

1.64

701

4417

(3027135) IgG subclass 1 [Mass/volume] in Serum

146

462

3.21

36.69

1.5

1.3

g/l

6.3

6.7

0.64

103

308

(3024139) IgG subclass 3 [Mass/volume] in Serum

146

462

3.21

36.69

1.5

1.3

g/l

0.4

0.62

102

307

(3028192) IgG subclass 2 [Mass/volume] in Serum

146

463

3.20

36.56

1.5

1.3

g/l

3.2

3.0

0.53

103

309

(3025941) Bacteria identified in Stool by Culture

529

2974

1.85

35.99

1.3

1.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

263

1154

2.33

35.00

1.9

1.6

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2185

17178

1.41

34.60

3.4

3.2

u/l

33.2

33.9

0.22

2076

16340

(3000494) Fungus identified in Specimen by Culture

853

5544

1.62

34.29

1.5

1.4

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

336

1647

2.10

34.02

1.7

g/l

1.5

0.85

280

1414

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

241

3.99

33.32

1.2

1.1

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

241

3.99

33.32

1.2

1.1

—

(3026008) Bacteria identified in Urine by Culture

1677

12653

1.44

33.17

3.1

2.7

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

242

3.97

33.13

1.2

1.1

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

165

595

2.82

32.99

1.2

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

268

1219

2.25

32.77

1.9

2.1

mg/l

10.3

10.5

0.14

249

1144

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

244

3.94

32.76

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

244

3.94

32.76

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

245

3.92

32.58

1.2

1.1

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

304

1462

2.13

32.35

2.1

1.9

ug/l

0.8

2.2

3.36

270

1328

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

5247

48067

1.46

31.53

4.8

4.4

mu/l

1.7

2.2

3.84

4910

44644

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1266

2.20

31.44

1.8

2.6

g/l

4.0

3.8

1.66

191

894

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

272

1267

2.20

31.38

1.8

2.6

g/l

7.3

7.1

0.98

199

946

(3007461) Platelets [#/volume] in Blood

6313

60567

2.19

31.06

29.9

16.3

e9/l

267.6

253.9

50.76

6263

59007

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

271

1266

2.19

31.04

1.8

2.6

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

152

4.71

30.99

1.1

iu/ml

3.4

3.6

—

(3037756) Immunofixation for Serum or Plasma

168

636

2.68

30.62

1.3

1.9

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

4509

40296

1.38

30.59

4.0

3.8

pmol/l

14.8

14.6

9.49

4170

37166

(3039162) Centromere protein B Ab [Units/volume] in Serum

125

403

3.14

30.50

1.4

1.1

u/ml

13.3

30.6

0.47

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

257

1188

2.21

30.22

1.7

2.6

g/l

3.2

3.0

1.96

196

925

(3035941) MCH [Entitic mass]

6313

60621

2.17

30.09

29.7

16.2

30.3

30.2

1.86

6286

59788

(3024731) MCV [Entitic volume]

6313

60625

2.17

30.02

29.7

16.2

91.2

90.4

36.57

6287

59793

(3026361) Erythrocytes [#/volume] in Blood

6313

60636

2.16

29.82

29.9

16.3

e12/l

4.5

4.6

42.29

6254

58950

(3000963) Hemoglobin [Mass/volume] in Blood

6314

60657

2.16

29.68

30.0

16.3

g/l

135.1

137.5

38.34

6285

59823

(3010813) Leukocytes [#/volume] in Blood

6313

60651

2.15

29.55

29.9

16.3

e9/l

6.9

6.6

17.25

6252

58943

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

697

4470

1.63

29.33

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

263

1242

2.16

29.32

2.9

2.7

—

(4034850)

309

1563

2.03

28.72

10.6

7.8

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

697

4510

1.61

28.23

1.7

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

484

2858

1.75

27.76

3.6

3.8

ng/l

85.9

87.9

0.15

425

2503

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

208

3.88

27.18

1.4

1.3

u/l

5.1

6.5

0.83

175

(36304315) Certolizumab Ab [Units/volume] in Serum or Plasma by Immunoassay

+∞

27.10

1.2

0.0

au/ml

235.8

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

225

3.72

26.58

1.2

1.1

u/ml

51.8

43.0

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

245

1175

2.13

26.27

1.8

2.6

g/l

10.8

10.3

0.90

209

995

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

1078

7783

1.46

26.14

2.6

3.1

mmol/l

2.4

0.22

937

6790

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

227

1060

2.18

26.06

1.9

2.6

g/l

0.7

1.1

0.68

201

927

(3004809) Band form neutrophils/100 leukocytes in Blood

160

646

2.51

25.64

2.8

3.5

1.5

0.01

125

511

(3044640) Blood type and Crossmatch panel - Blood

1859

14816

1.36

25.19

2.4

2.2

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

207

947

2.22

25.00

1.8

2.5

g/l

0.0

1.56

192

870

(40768443) Skin Pathology biopsy report

355

1972

1.85

24.97

1.2

—

(3013512) EKG study

1592

12406

1.37

24.83

3.6

3.4

—

(3022217) INR in Platelet poor plasma by Coagulation assay

749

5096

1.53

24.18

19.4

19.2

inr

1.3

0.06

134

740

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

1442

11152

1.38

23.35

2.3

2.2

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

1467

11398

1.37

23.03

1.8

1.6

—

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

112

403

2.81

22.60

1.2

u/l

50.7

61.0

1.14

271

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

555

3581

1.60

22.57

2.5

2.4

ml/min/173m2

69.6

72.0

0.63

202

1324

(3019225) pH of Specimen

610

4043

1.56

22.09

3.9

3.8

—

(3044927) Protein electrophoresis panel - Urine

273

3.18

21.65

1.2

1.1

—

(40760888) Immunoglobulin light chains.free panel - Serum

169

763

2.25

21.13

2.1

3.9

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

259

1376

1.92

20.93

1.2

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

205

1003

2.08

20.91

2.4

3.9

mg/l

28.2

50.5

2.67

152

821

(3003458) Phosphate [Moles/volume] in Serum or Plasma

777

5481

1.47

20.90

5.5

6.1

mmol/l

1.0

0.83

719

5132

(3005322) IgE [Units/volume] in Serum or Plasma

521

3372

1.59

20.88

1.4

1.3

u/ml

243.7

238.0

0.03

499

3128

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

201

977

2.09

20.87

2.4

3.8

ratio

1.6

3.5

0.79

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

202

984

2.09

20.85

1.6

1.4

—

(42529406) Shigella sp [Presence] in Stool by Culture

260

1389

1.91

20.67

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

259

1383

1.91

20.62

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

204

1003

2.07

20.55

2.4

3.9

mg/l

40.8

102.0

0.56

152

818

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

199

975

2.07

20.24

1.8

2.5

g/l

37.9

38.3

0.43

178

845

(3009871) Measles virus Ab [Titer] in Serum

186

3.52

19.32

1.7

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

614

4208

1.51

18.97

2.4

2.3

g/l

0.2

0.60

565

3941

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

181

884

2.08

18.59

1.9

2.6

g/l

0.0

0.00

166

810

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

4276

39031

1.28

18.50

3.4

3.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

302

1751

1.76

18.44

2.1

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

116

474

2.47

18.24

1.3

1.4

titre

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

280

1601

1.78

17.93

2.0

1.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

626

4359

1.48

17.86

3.8

3.1

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

177

872

2.06

17.78

1.9

2.6

g/l

0.0

0.00

165

809

(3022621) pH of Urine by Test strip

454

2958

1.57

17.65

3.5

2.5

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

530

3588

1.52

17.33

3.7

3.8

mmol/l

1.2

0.05

479

3113

(3008757) Leukocyte morphology finding [Identifier] in Blood

103

408

2.55

17.31

2.3

4.0

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

391

2476

1.62

17.14

3.7

3.2

kpa

5.2

0.62

354

2308

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

947

7160

1.38

17.07

3.0

2.6

e6/l

2.6

2.7

0.11

539

3744

(3009343) pH of Capillary blood

386

2446

1.61

16.87

3.6

3.2

7.4

0.21

309

(3003327) Ova and parasites identified in Stool by Light microscopy

303

1806

1.71

16.78

1.7

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

212

1141

1.89

16.53

1.4

1.3

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

1111

8659

1.34

16.41

3.6

3.3

ng/l

610.2

643.5

0.05

735

6045

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

373

2363

1.61

16.32

3.6

3.1

mmol/l

1.9

1.7

0.52

267

1730

(3016650) Hepatitis A virus Ab [Presence] in Serum

178

913

1.98

16.02

1.1

—

(3019060) Gas panel - Arterial blood

404

2626

1.57

15.86

4.5

5.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

157

775

2.05

15.73

1.4

1.5

—

(40768804) Tissue Pathology biopsy report

2402

20769

1.25

15.57

2.1

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

357

2269

1.61

15.42

2.7

2.4

e6/l

0.4

0.3

0.46

342

2192

(3052851) Hemolysis interference index of Serum or Plasma

229

1296

1.79

15.23

2.6

3.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

730

5384

1.40

15.18

6.8

5.7

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

393

2.46

15.11

2.3

3.6

57.9

57.0

0.12

260

(3044889) 12 lead EKG panel

3817

34758

1.24

15.08

3.5

3.2

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

134

3.60

14.88

1.1

1.0

—

(3005011) Chlamydia sp Ab [Titer] in Serum

5.10

14.55

1.4

1.6

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

179

954

1.90

14.43

3.0

6.1

iu/ml

1482.3

785.3

0.40

136

(3001729) Color of Synovial fluid

11.56

14.42

2.1

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

139

681

2.06

14.25

1.5

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

969

7548

1.33

14.20

1.9

2.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

363

2.47

14.14

1.3

1.2

titre

308.3

271.1

0.12

(3013293) Extractable nuclear Ab [Presence] in Serum

8.59

14.12

1.5

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

340

2.52

14.08

1.4

1.2

—

(3020961) Endomysium IgA Ab [Titer] in Serum

382

2525

1.54

13.94

1.2

1.1

titre

79.4

246.7

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

752

5651

1.37

13.92

2.6

2.7

umol/l

7.3

7.8

0.26

648

4901

(36660697) Celiac disease serology panel - Serum

583

4195

1.43

13.92

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

342

2.50

13.91

1.4

1.2

—

(3020891) Body temperature

268

1627

1.67

13.91

4.5

4.6

—

(3049717) Cytology report of Urine Cyto stain

239

1413

1.72

13.69

2.6

—

(3016502) Oxygen saturation in Arterial blood

576

4172

1.42

13.24

6.8

8.4

95.5

95.8

0.50

554

4019

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

224

2.83

13.16

1.1

1.2

u/l

24.1

22.6

0.06

191

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

178

977

1.84

13.13

1.4

1.7

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

334

2174

1.57

13.06

2.4

2.3

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

121

585

2.09

12.90

1.3

1.4

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

929

7289

1.32

12.85

3.0

3.5

mmol/l

0.8

1.57

873

6836

(3014576) Chloride [Moles/volume] in Serum or Plasma

719

5432

1.36

12.83

6.6

7.3

mmol/l

104.0

104.6

2.77

703

5318

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

112

529

2.14

12.69

1.2

1.5

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

229

1368

1.70

12.65

1.9

2.4

ug/l

299.7

670.8

1.21

202

1292

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

1050

8397

1.30

12.61

1.9

2.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

311

2.49

12.54

1.4

2.2

—

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

638

4748

1.38

12.50

6.5

7.8

kpa

5.1

0.63

609

4538

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

145

757

1.94

12.49

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

416

2867

1.48

12.46

1.4

—

(3011412) CD3 cells [#/volume] in Blood

443

2.23

12.39

1.7

2.7

e9/l

1.2

0.20

252

(3027801) Oxygen [Partial pressure] in Arterial blood

637

4746

1.38

12.39

6.5

7.8

kpa

12.4

12.9

1.82

607

4543

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

173

959

1.83

12.39

1.5

1.7

—

(3022313) Gas panel - Capillary blood

280

1772

1.61

12.35

4.0

3.2

—

(3042631) Mycobacterium sp identified in Specimen

105

490

2.16

12.28

2.6

2.7

—

(3014051) Protein [Presence] in Urine by Test strip

172

955

1.82

12.26

2.3

1.9

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

268

2.59

12.19

1.4

1.7

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

246

2.66

12.10

1.6

u/l

6.3

4.5

0.43

116

(21494755) Public health laboratory ask at order entry panel

562

7526

0.72

11.88

1.3

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

166

3.03

11.84

1.2

1.1

—

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

246

1526

1.64

11.79

4.2

3.3

mmol/l

25.0

24.7

0.99

225

1421

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

178

2.94

11.68

1.2

1.1

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

139

733

1.92

11.65

1.1

1.2

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

133

692

1.94

11.60

1.3

1.4

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

112

550

2.05

11.50

1.7

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

112

551

2.05

11.45

1.7

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

112

551

2.05

11.45

1.7

1.5

—

(3037121) Protein [Mass/volume] in Urine

236

1462

1.64

11.38

3.2

g/l

0.3

0.19

117

651

(3025468) Yersinia sp identified in Specimen by Organism specific culture

111

546

2.05

11.35

1.7

1.5

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

314

2.40

11.35

1.2

1.1

ratio

1.1

0.41

115

(3024522) Salmonella sp identified in Specimen by Organism specific culture

111

548

2.04

11.24

1.7

1.5

—

(3003396) Base excess in Arterial blood by calculation

629

4751

1.36

11.20

6.6

7.8

mmol/l

1.0

0.9

0.16

481

3700

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.66

11.20

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

113

563

2.02

11.17

1.7

1.5

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

465

2.12

11.03

1.1

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

4948

46880

1.23

11.01

5.2

4.9

mmol/mol

38.0

39.0

11.40

4664

43785

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

342

2331

1.49

10.84

1.7

1.6

—

(3018405) Lactate [Moles/volume] in Arterial blood

228

1420

1.63

10.78

3.9

4.0

mmol/l

1.3

1.4

0.91

220

1395

(3013637) Mi-2 Ab [Presence] in Serum

4.30

10.74

1.1

1.0

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

4.30

10.74

1.1

1.0

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

4.30

10.74

1.1

1.0

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

4.30

10.74

1.1

1.0

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

364

2522

1.47

10.63

7.0

7.4

mmol/l

24.8

24.4

1.10

340

2358

(3033658) Prothrombin time (PT) actual/Normal

1469

12448

1.23

10.61

4.0

3.8

93.3

92.6

0.61

1425

12149

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

101

495

2.06

10.47

1.3

1.4

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

396

2.19

10.46

1.1

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

455

2.10

10.46

2.4

1.9

mg/l

25.8

23.8

0.12

123

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

5265

50305

1.24

10.30

4.2

3.9

mmol/l

5.8

1.29

4876

46566

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

158

904

1.77

10.25

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

368

2.22

10.20

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

370

2.20

10.07

1.1

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

106

539

1.98

9.94

1.2

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

283

1890

1.52

9.92

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

460

3377

1.39

9.77

2.6

2.2

ug/l

6.6

8.1

0.36

398

3016

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

189

1163

1.64

9.43

1.2

—

(3015183) Erythrocyte sedimentation rate

304

2.28

9.38

1.3

1.1

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

330

2.23

9.34

1.7

1.9

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

330

2.23

9.34

1.7

1.9

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

330

2.23

9.34

1.7

1.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

311

2.26

9.33

1.2

1.1

—

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

197

2.60

9.21

1.1

u/l

20.5

22.4

0.08

147

(3043409) Potassium [Moles/volume] in Arterial blood

195

1217

1.62

9.20

4.0

4.2

mmol/l

3.8

3.9

0.75

185

1142

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

124

684

1.83

9.14

1.5

1.8

—

(3028433) Virus identified in Specimen by Culture

121

3.07

9.06

1.3

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

355

2.15

8.98

1.5

2.2

13.4

15.6

0.89

157

(3000570) Elastase.pancreatic [Mass/mass] in Stool

202

1280

1.60

8.97

1.4

ug/g

263.5

273.8

0.28

112

740

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

117

3.09

8.92

1.2

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

354

2531

1.42

8.79

1.6

1.5

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

128

726

1.78

8.63

1.8

2.8

u/ml

159.0

997.3

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

512

3903

1.34

8.57

7.5

8.8

g/l

121.4

123.2

1.17

493

3764

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

501

6510

0.75

8.55

1.6

1.7

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

500

3802

1.34

8.52

6.1

7.3

mmol/l

1.4

0.05

481

3661

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

141

826

1.72

8.50

1.1

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

324

2.17

8.49

1.7

2.9

e6/l

508.8

514.2

0.03

273

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

200

2.51

8.44

1.1

u/l

78.9

90.3

0.31

153

(3012516) Albumin [Mass/volume] in Urine

1458

12592

1.20

8.43

3.1

3.2

mg/l

874.3

374.6

1.99

913

8039

(3014148) Varicella zoster virus Ab [Titer] in Serum

136

791

1.73

8.42

1.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

313

2.18

8.37

1.8

3.0

e9/l

0.2

0.23

269

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

144

853

1.70

8.35

1.5

1.6

—

(3009542) Hematocrit [Volume Fraction] of Blood

5317

51117

1.21

8.34

19.8

12.0

40.0

40.5

4.46

3847

40247

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

422

3140

1.37

8.28

2.6

2.7

ng/l

147.2

160.0

0.32

381

2837

(3018677) aPTT in Platelet poor plasma by Coagulation assay

851

6976

1.25

8.14

2.0

2.2

29.8

29.7

0.21

816

6778

(3010421) pH of Blood

187

1192

1.59

8.13

3.5

3.7

7.4

1.25

160

996

(3012501) Base excess in Blood by calculation

164

1014

1.63

8.09

3.6

3.7

mmol/l

2.9

2.4

1.23

118

668

(1616796) Gas panel - Central venous blood

158

968

1.65

8.08

3.0

3.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

178

1124

1.60

8.06

1.2

1.3

mmol/l

3.6

3.8

2.56

163

1055

(1761868) Lipid panel - Serum or Plasma

1947

21768

0.85

8.05

2.6

2.5

—

(3009508) Creatinine [Moles/volume] in Urine

1634

14314

1.19

8.01

3.1

3.2

mmol/l

7.8

8.1

1.38

1395

12238

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

182

2.54

7.96

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

4.87

7.87

1.0

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

174

1100

1.60

7.85

1.2

u/ml

299.9

253.2

1.17

109

710

(3029075) Extractable nuclear Ab panel - Serum

121

2.90

7.83

1.1

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

179

1144

1.58

7.72

1.3

1.4

e6/l

66.0

16.6

0.94

146

876

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

179

1145

1.58

7.69

1.4

e6/l

3868.7

4372.7

0.04

152

933

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

173

1098

1.59

7.69

1.3

1.4

—

(3020779) Urea [Moles/volume] in Serum or Plasma

488

3757

1.32

7.65

7.0

7.7

mmol/l

9.1

8.7

0.51

462

3597

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

196

1287

1.54

7.52

1.3

mg/l

591.0

487.6

0.48

184

1223

(21494815) CD4 cells/100 lymphocytes in Specimen

409

1.97

7.50

1.7

2.5

46.4

41.8

0.39

(3017704) Immunofixation for Urine

176

2.51

7.47

1.4

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

135

812

1.68

7.44

1.2

u/ml

5.6

3.4

0.38

261

(3012544) pH of Venous blood

512

3989

1.31

7.37

4.2

3.7

—

7.4

—

(40767503) Oxygen content in Capillary blood by calculation

144

884

1.64

7.34

2.1

2.2

16.8

0.02

421

(3002032) Base excess in Venous blood by calculation

495

3843

1.31

7.31

4.2

3.7

mmol/l

1.9

1.8

0.19

406

3131

(3021901) Oxygen saturation in Capillary blood

121

711

1.72

7.28

2.1

2.7

—

(3021447) Carbon dioxide [Partial pressure] in Venous blood

496

3859

1.31

7.21

4.2

3.7

kpa

6.0

5.8

2.44

488

3751

(21494890) Protein electrophoresis panel - 24 hour Urine

348

2.02

7.12

1.9

2.4

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

106

2.93

7.10

1.9

1.4

ug/l

8.2

8.8

0.33

106

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

283

2.13

7.01

1.1

miu/ml

1417.5

1488.3

0.21

283

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

207

1398

1.50

6.99

1.2

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

435

1.90

6.93

1.1

mg/l

286.4

284.1

0.10

394

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

520

0.25

6.90

12.9

18.6

nmol/l

1406.2

3245.0

0.50

505

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

148

2.58

6.84

1.2

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

154

984

1.58

6.70

2.6

3.0

mmol/l

25.1

24.8

0.33

127

862

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

157

1008

1.57

6.70

1.3

1.5

u/ml

98.8

112.0

1.08

219

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

119

715

1.68

6.63

1.1

g/l

1.5

0.37

107

646

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

310

2.04

6.61

1.8

u/field

1.1

2.1

1.27

126

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

537

1.78

6.58

1.2

1.5

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

3.45

6.55

1.1

1.6

nmol/l

6.9

663164.3

1.08

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

360

2716

1.34

6.51

2.1

2.3

u/l

4007.0

5467.8

0.52

134

1079

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

500

3949

1.29

6.51

1.2

iu/ml

87.2

148.2

4.37

173

1521

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

218

1513

1.46

6.44

1.4

1.3

—

(3028626) Oxygen [Partial pressure] in Capillary blood

137

862

1.60

6.38

2.3

2.9

kpa

8.2

8.3

0.29

125

799

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

114

685

1.68

6.37

1.3

1.2

nmol/l

0.1

0.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

1497

13235

1.17

6.36

3.9

mg/mmol

12.9

9.4

1.56

952

8561

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

134

840

1.61

6.34

2.7

3.0

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

269

1950

1.40

6.26

3.6

3.3

mmol/l

25.5

25.2

0.80

262

1890

(3000330) Specific gravity of Urine by Test strip

286

2097

1.38

6.22

3.5

3.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

370

1.90

6.03

1.2

1.1

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

4.82

5.97

1.0

1.2

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

139

893

1.57

5.96

1.9

2.1

g/l

132.8

132.2

0.10

105

645

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

438

1.81

5.88

1.8

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

339

4412

0.76

5.85

1.3

1.4

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

124

779

1.60

5.85

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

199

2.22

5.77

1.3

1.2

—

(3024354) Oxygen [Partial pressure] in Venous blood

401

3130

1.30

5.74

3.7

3.2

kpa

4.7

0.04

394

3037

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

213

1508

1.43

5.71

1.1

u/ml

3.4

7.3

1.25

240

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

150

2.41

5.69

1.1

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

262

1927

1.37

5.63

3.2

2.8

0.7

0.6

1.20

247

1844

(3017446) Testosterone [Moles/volume] in Serum or Plasma

535

4340

1.25

5.61

2.1

2.2

nmol/l

13.0

13.1

0.11

476

3918

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

4.49

5.50

1.5

1.6

mg/l

0.4

1.9

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

146

968

1.52

5.47

1.3

1.4

u/l

22.1

24.5

0.43

123

808

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

264

2.02

5.45

1.2

1.1

nmol/l

0.1

12.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

135

2.45

5.43

1.5

2.1

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

444

1.77

5.36

1.1

mg/l

252.1

258.7

0.06

386

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

393

1.82

5.35

1.9

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

469

3772

1.26

5.31

1.7

1.9

—

(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma

3.28

5.29

2.5

2.1

—

(3047181) Lactate [Moles/volume] in Blood

190

1337

1.43

5.29

5.6

6.7

mmol/l

1.3

0.03

168

1174

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

286

2155

1.34

5.28

1.3

miu/ml

216.4

229.1

0.25

125

1033

(3026029) Penicillin V IgE Ab [Units/volume] in Serum

4.62

5.25

1.1

u/ml

0.6

0.2

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

570

4692

1.24

5.25

2.6

2.5

u/l

97.9

48.6

0.37

484

4054

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

221

2.09

5.22

1.7

1.6

u/field

1.6

3.8

1.28

157

(3000991) Gas panel - Venous blood

444

3561

1.26

5.15

7.7

8.7

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

457

1.74

5.15

1.2

mg/l

31.1

39.8

2.91

375

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

100

617

1.63

5.13

1.3

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

313

1.89

5.09

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

217

2.08

5.07

1.8

2.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

3.56

5.04

1.1

—

(3037297) Penicillin G IgE Ab [Units/volume] in Serum

4.79

5.01

1.1

u/ml

0.2

—

(3023419) Bacteria identified in Sputum by Culture

491

1.70

5.00

2.1

2.7

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

478

1.70

4.93

1.0

1.1

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

463

1.71

4.93

1.2

1.6

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

3.12

4.90

2.5

2.0

mg/l

19.4

20.0

0.08

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

162

1124

1.45

4.89

1.7

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

318

1.86

4.87

1.2

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

155

1068

1.46

4.86

1.3

1.4

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

373

2951

1.28

4.85

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1439

12912

1.15

4.85

1.6

mmol/l

1.4

0.80

1214

10991

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

4.29

4.82

1.4

1.5

mg/l

1.9

1.4

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

4.29

4.82

1.4

1.5

mg/l

1.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

305

1.88

4.81

1.2

1.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

330

2575

1.30

4.79

3.8

3.3

g/l

130.3

131.7

0.49

323

2523

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

416

3344

1.26

4.75

2.8

3.4

pmol/l

4.6

4.5

0.12

368

3006

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

228

1691

1.36

4.71

5.3

5.7

1.6

1.7

0.53

219

1585

(3032057) Clostridioides difficile [Presence] in Stool

2.79

4.70

2.6

2.0

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

217

2.03

4.70

1.9

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

217

2.03

4.70

1.9

2.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

217

2.03

4.70

1.9

2.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

440

1.71

4.69

1.5

1.6

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

5421

52786

1.16

4.67

4.2

3.9

mmol/l

4.7

4.8

4.17

5117

49665

(44790048)

471

1.69

4.66

1.4

1.5

—

(44806118)

471

1.69

4.66

1.4

1.5

—

(44790047)

471

1.69

4.66

1.4

1.5

—

(44790049)

471

1.69

4.66

1.4

1.5

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

352

1.80

4.66

2.4

2.9

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

175

1245

1.42

4.64

2.8

3.0

mg/l

1.5

1.4

0.95

162

1169

(3000492) Spirometry study

633

5343

1.20

4.56

1.4

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

3961

37868

1.12

4.47

3.3

2.9

u/l

50.2

44.0

3.75

3727

35858

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

142

2.26

4.46

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

5484

53488

1.16

4.43

4.5

4.3

mmol/l

2.8

2.9

4.59

5144

50019

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

175

2.12

4.42

3.8

4.2

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

532

1.62

4.42

1.1

—

(3013727) Leukocytes other/100 leukocytes in Blood

130

2.31

4.42

4.3

4.0

50.7

55.1

0.49

124

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.62

4.38

1.0

1.2

—

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

3.72

4.36

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

117

783

1.50

4.28

1.2

u/ml

3.4

4.1

0.53

349

(3008295) Osmolality of Serum or Plasma

437

1.68

4.27

1.4

mosm/kgh2o

278.5

281.8

0.62

344

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

430

1.68

4.25

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

1611

14676

1.13

4.24

4.4

4.3

ug/l

3.2

2.7

0.34

1452

13317

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

269

1.87

4.20

1.8

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

327

1.78

4.20

1.1

u/l

1.3

1.0

0.83

144

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

262

1.88

4.20

1.8

1.4

—

(4010399)

404

3289

1.24

4.17

1.4

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

174

2.07

4.10

1.1

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

222

1679

1.33

4.08

5.4

5.7

0.9

0.36

212

1577

(3036048) Francisella tularensis Ab [Titer] in Serum

116

2.33

4.07

1.1

—

62.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

642

5485

1.19

4.06

4.0

3.9

32.4

31.6

1.09

479

3838

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

265

1.86

4.06

2.0

2.8

45.2

41.9

0.49

(4027681)

361

1.72

4.03

1.2

1.3

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

210

1.96

4.00

1.2

1.5

—

(3001019) Free T4 and TSH panel - Serum or Plasma

295

3708

0.79

3.96

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

213

1.93

3.85

1.2

1.5

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

5376

52473

1.14

3.84

4.1

3.9

mmol/l

1.5

0.51

5054

49167

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

159

2.08

3.81

1.6

1.2

113.8

110.4

0.26

149

(3035320) C reactive protein [Mass/volume] in Body fluid

330

1.73

3.80

2.9

2.1

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

565

4811

1.19

3.73

1.9

—

(3045716) Anion gap in Serum or Plasma

174

2.02

3.73

1.6

2.4

mmol/l

8.7

9.3

0.52

126

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

340

1.71

3.71

2.0

3.1

e6/l

907.0

727.4

0.81

148

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

122

854

1.44

3.62

1.2

1.1

au/ml

12.8

11.5

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

195

1476

1.33

3.61

2.3

2.6

g/l

3.8

3.6

1.04

181

1403

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

178

1331

1.35

3.58

1.9

pmol/l

202.9

204.3

0.06

172

1271

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

237

1.82

3.41

1.2

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

126

2.15

3.41

1.1

—

(21494814) CD8 cells/100 lymphocytes in Specimen

195

1.90

3.37

1.6

2.2

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

2.47

3.29

1.2

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

115

2.18

3.27

1.0

1.7

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

114

1592

0.71

3.27

1.5

—

(40768441) Liver Pathology biopsy report

372

1.62

3.16

1.1

1.4

—

(3023410) Appearance of Cerebral spinal fluid

523

1.52

3.15

1.4

1.6

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

281

1.71

3.14

1.5

1.6

iu/ml

—

1798876.1

—

(3006270) Folate [Moles/volume] in Blood

404

1.59

3.14

1.2

1.1

nmol/l

378.0

389.2

0.15

361

(3000060) B lymphocytes [#/volume] in Blood

124

2.10

3.13

1.3

2.3

e6/l

164.0

164.8

0.01

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

590

1.48

3.10

1.3

1.4

pmol/l

215.3

348.8

1.76

449

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

282

2288

1.24

3.08

9.2

10.8

—

(3000093) Morphology [Interpretation] in Blood Narrative

345

1.63

3.04

1.3

1.1

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

514

1.50

2.97

1.1

—

(3000012) Reticulocyte production index

212

1.80

2.95

1.6

1.5

—

(3011985) Renin [Units/volume] in Plasma

630

1.45

2.94

1.7

1.5

mu/l

54.1

58.7

0.12

565

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

191

1.84

2.91

1.4

1.5

pmol/l

14.8

15.4

0.22

161

(3047352) Trisomy 18 risk [Likelihood] in Fetus

113

1544

0.73

2.88

1.5

1.4

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

2.59

2.87

1.1

1.2

63.1

57.7

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

115

835

1.38

2.86

1.9

2.1

umol/l

5.9

5.8

0.05

618

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

121

886

1.37

2.86

3.8

u/ml

325.1

674.9

0.51

104

815

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

116

2.07

2.82

1.1

—

(3005033) Fetal Nuchal fold Thickness US

113

1538

0.73

2.82

1.4

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

276

2259

1.23

2.81

8.1

10.0

mmol/l

24.5

24.2

0.76

253

2137

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

2.65

2.79

17.3

9.5

mmol/l

4.9

6.3

1.25

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.55

2.78

2.1

2.7

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

104

2.12

2.74

1.1

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

175

1.83

2.67

1.6

1.2

g/l

0.3

0.16

143

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

2.18

2.66

1.2

1.4

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

112

2.06

2.66

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

5174

50651

1.10

2.65

3.8

3.6

mmol/l

1.3

0.51

4842

47278

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1037

9450

1.12

2.65

1.5

—

(3006462) Nitrate [Presence] in Urine

213

1.74

2.62

4.4

2.4

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

162

1.86

2.61

2.3

2.5

—

(4211845)

236

1.70

2.60

4.4

2.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

313

1.60

2.60

1.1

iu/ml

12.6

8.1

0.28

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

244

1991

1.23

2.59

1.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

758

6793

1.13

2.58

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

260

1.66

2.56

1.1

—

(3023183) Ammonium ion [Moles/volume] in Plasma

127

959

1.33

2.50

2.5

3.1

umol/l

32.3

34.4

0.58

106

822

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.46

2.48

1.3

1.1

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.82

2.47

1.0

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

2.94

2.41

1.0

—

(3018291) Platelet Ab [Presence] in Serum

6.25

2.37

1.0

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

6.25

2.37

3.8

1.3

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

165

1303

1.27

2.36

3.4

3.2

u/ml

0.4

0.3

0.35

724

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

228

1.67

2.35

1.5

1.7

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

248

2052

1.22

2.33

4.8

4.0

mmol/l

24.1

0.01

217

1857

(3009214) Lutropin [Units/volume] in Serum or Plasma

235

1936

1.22

2.31

1.4

u/l

9.6

9.5

0.05

196

1605

(3048879) Bone marrow aspiration report

2.04

2.31

1.5

2.5

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

162

1.79

2.30

2.3

2.5

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

162

1.79

2.30

2.3

2.5

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

177

1.75

2.29

1.2

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

177

1.75

2.29

1.2

1.5

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

155

1.81

2.29

2.1

3.8

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

163

2044

0.79

2.28

1.5

—

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

2.23

2.27

2.4

2.6

—

(37019676) Renin [Units/volume] in Plasma --supine

4.62

2.27

1.0

1.1

mu/l

18.6

14.2

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

254

1.62

2.26

1.5

1.4

u/ml

20.5

18.0

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

263

1.60

2.22

1.1

102.4

92.3

1.18

209

(3026480) Teichoate Ab [Titer] in Serum

3.11

2.22

1.0

1.1

—

(3039000) Anion gap in Blood

123

944

1.31

2.21

7.1

8.1

mmol/l

11.0

11.2

0.33

115

848

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

121

1.90

2.20

1.1

—

(3018572) Chloride [Moles/volume] in Blood

123

945

1.31

2.19

7.1

8.1

mmol/l

105.4

105.2

0.19

115

849

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.07

2.16

1.3

1.1

umol/24h

0.7

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

122

1.89

2.15

1.2

1.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.69

2.15

1.3

mmol/l

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

391

3395

1.16

2.15

1.2

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

151

0.33

2.13

1.0

1.1

u/ml

95.5

55.4

—

143

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

395

1.47

2.13

2.7

2.6

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

123

1.87

2.11

1.0

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.45

2.10

1.0

1.1

—

(3030313) Adrenal Ab [Titer] in Serum

2.56

2.09

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

115

882

1.31

2.09

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

115

882

1.31

2.09

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

190

1.69

2.09

2.1

1.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

190

1.69

2.09

2.1

1.5

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

284

1.55

2.07

1.3

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

366

1.48

2.04

1.3

u/ml

0.2

1.1

1.49

151

(3034614) HLA Ag [Interpretation]

4.00

2.04

1.2

1.3

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

184

1.69

2.03

2.9

3.6

—

(3022689) Creatine [Moles/volume] in Urine

132

1.82

2.03

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

185

1.68

2.00

1.2

1.1

ng/l

685.6

485.1

—

(3040151) Glucose [Moles/volume] in Capillary blood

478

1.41

1.95

5.8

19.8

mmol/l

6.7

7.3

0.98

396

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.55

1.94

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

2.97

1.93

1.0

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

187

1.66

1.93

1.0

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.45

1.92

1.0

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

120

1.84

1.92

1.0

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

242

1.57

1.92

1.1

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

2.24

1.90

2.6

1.4

—

(4268621)

557

1.37

1.90

2.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

722

1.32

1.88

1.2

—

(3003338) MCHC [Mass/volume]

4877

47845

1.08

1.84

24.8

14.0

g/l

331.8

333.4

30.71

4861

47473

(44813793)

375

1.44

1.84

1.2

1.1

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

821

0.72

1.81

4.8

5.3

umol/l

337.7

371.9

1.25

721

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

238

1.56

1.81

1.4

1.6

nmol/l

2.4

5.0

0.66

189

(3027570) Oxalate [Moles/time] in 24 hour Urine

2.57

1.80

1.4

umol/24h

224.6

299.8

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

161

1316

1.23

1.78

1.6

2.0

iu/l

3.8

4.1

0.19

538

(3016018) Differential panel - Cerebral spinal fluid

556

1.35

1.77

1.3

1.4

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

362

1.44

1.76

1.8

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

379

1.43

1.75

3.9

4.0

—

(3036603) Volume of Urine

305

1.48

1.74

1.8

1521.8

2089.0

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

2.67

1.72

1.0

1.1

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.67

1.72

1.0

1.1

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

3.85

1.71

1.0

1.2

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

415

1.40

1.70

1.4

1.3

mmol/l

2.2

1.9

0.61

391

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

250

1.52

1.70

1.5

1.2

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

157

1903

0.82

1.69

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

157

1901

0.82

1.67

1.4

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

172

1.63

1.66

1.0

1.2

96.3

91.3

0.27

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

157

1895

0.82

1.63

1.4

—

(3004451) EKG impression Narrative

181

1.60

1.63

1.1

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

157

1892

0.83

1.60

1.4

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.33

1.60

1.3

1.1

umol/24h

1.7

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

2.69

1.58

1.0

—

(3011325) HIV 1+2 Ab [Presence] in Serum

2.69

1.58

1.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

346

1.42

1.57

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

183

1.59

1.56

2.5

2.2

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

373

3314

1.13

1.55

1.4

1.3

iu/l

24.0

27.2

1.15

322

2864

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

105

834

1.26

1.54

1.1

121.9

115.9

1.63

758

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

2.03

1.54

1.5

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

144

1186

1.22

1.53

1.2

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

138

1.67

1.51

1.1

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

109

875

1.25

1.48

1.1

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

192

1632

1.18

1.47

2.0

2.2

94.1

92.4

0.46

178

1510

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.22

1.46

1.3

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

102

1.77

1.44

1.2

1.1

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

2.12

1.44

1.2

1.1

—

(3036489) Thrombin time

221

1904

1.17

1.44

2.0

2.1

21.1

21.2

0.14

180

1636

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

2.31

1.42

2.2

2.5

u/field

0.4

0.7

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

110

1.73

1.42

1.1

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

400

0.65

1.41

1.0

1.1

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

100

802

1.25

1.38

1.4

1.6

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

2.08

1.38

1.3

1.2

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

1242

11757

1.07

1.36

3.8

3.7

21.4

21.8

0.50

584

5105

(3000034) Microalbumin [Mass/volume] in Urine

417

1.35

3.3

2.8

mg/l

102.3

60.2

0.22

308

(3052592) Norovirus Ag [Presence] in Stool

1.87

1.34

1.8

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

183

1.53

1.34

1.0

1.1

99.4

89.4

1.47

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.14

1.33

1.1

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

224

1.48

1.33

2.4

2.2

umol/l

238.8

158.7

0.28

105

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

233

2032

1.15

1.32

1.6

1.7

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

533

1.30

1.2

1.3

pmol/l

74.6

73.0

0.03

161

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

351

1.37

1.30

1.3

1.2

—

(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid

2.50

1.30

1.8

1.1

mg/l

0.0

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

508

1.30

1.28

3.0

2.9

nmol/l

0.8

0.08

381

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

2.78

1.28

1.0

1.1

—

(3014271) Vancomycin [Susceptibility]

153

1.57

1.28

3.9

2.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

230

2009

1.15

1.28

1.4

—

(3020491) Glucose [Moles/volume] in Blood

379

1.35

1.26

1.6

mmol/l

6.8

6.2

1.04

273

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

440

1.32

1.25

1.6

1.5

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

107

1.68

1.25

1.3

nmol/l

187.4

127.4

0.36

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

216

0.55

1.24

5.8

6.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

216

0.55

1.24

2.9

3.2

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

108

1.67

1.22

1.7

—

(3044009) aPTT.lupus sensitive (LA screen)

2.16

1.21

1.3

1.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

1130

0.81

1.21

1.5

1.6

—

(3051593) INR in Capillary blood by Coagulation assay

172

1.51

1.20

10.5

11.3

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

2.31

1.18

1.3

5.9

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

506

1.29

1.18

4.0

4.8

u/ml

116.7

67.1

0.22

151

(3003694) ABO and Rh group [Type] in Blood

1603

15366

1.06

1.17

1.5

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.93

1.16

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.50

1.15

1.0

1.2

—

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

110

1.64

1.15

1.1

1.2

pmol/l

223.4

281.6

—

(3034426) Prothrombin time (PT)

207

1.45

1.14

1.2

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.33

1.12

1.0

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

159

1370

1.16

1.10

1.5

1.3

—

(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum

1.82

1.08

1.8

1.1

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.67

1.03

1.0

1.1

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.83

1.02

1.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

316

1.33

1.00

5.7

6.8

—

(21494434) Karyotype in Bone marrow

334

1.32

0.99

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

107

1.59

0.99

1.0

1.1

91.2

79.5

—

(3021387) Prolactin [Units/volume] in Serum or Plasma

273

2460

1.11

0.99

1.7

mu/l

292.8

298.3

0.10

250

2232

(4281824)

539

0.76

0.99

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.84

0.98

1.3

1.0

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.80

0.98

1.3

4.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.80

0.98

1.1

—

(3035637) Corticotropin [Mass/volume] in Plasma

629

1.23

0.98

1.4

1.6

—

(3009677) Dengue virus Ab [Presence] in Serum

2.17

0.98

1.2

1.1

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

2.17

0.98

3.6

3.8

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

1.85

0.96

1.4

1.1

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

108

1.58

0.96

1.1

1.2

48.4

73.2

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

489

0.76

0.93

1.7

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

652

1.21

0.92

1.7

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

358

1.29

0.89

1.0

1.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

1.69

0.88

1.4

1.1

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

1.79

0.87

1.4

1.3

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

870

0.83

0.87

1.4

1.3

mmol/l

6.8

7.1

0.51

640

(21494567) Legionella sp IgM Ab [Presence] in Serum

2.00

0.87

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

127

1102

1.16

0.86

2.1

2.4

ug/min

104.5

130.3

0.35

711

(4306422)

100

852

1.18

0.85

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

247

1.34

0.85

1.8

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

170

1.41

0.85

2.4

2.3

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

230

1.35

0.84

1.1

1.2

—

(3014891) Appearance of Pleural fluid

1.74

0.82

1.6

1.7

—

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

266

1.32

0.82

1.1

1.2

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

163

1.41

0.81

1.7

2.8

—

(3029396) Erythrocyte agglutination [Presence] in Blood

189

0.63

0.81

3.3

2.8

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

848

1.17

0.80

1.1

u/ml

1.7

3.6

1.87

464

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.73

0.79

1.4

1.3

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.82

0.79

1.0

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

190

1.37

0.78

1.6

6.7

mg/l

72.5

63.3

0.36

128

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

1.67

0.78

1.5

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

565

1.21

0.78

1.1

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

429

1.24

0.78

1.2

1.3

nmol/l

1.7

1.4

1.23

386

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

331

3576

0.92

0.76

1.5

—

(3020650) Glucose [Presence] in Urine

149

1.41

0.75

1.8

1.4

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

166

1.39

0.75

2.8

2.5

—

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

290

2668

1.09

0.75

2.6

3.4

u/ml

35.2

47.2

0.94

276

2583

(3019897) Erythrocyte distribution width [Ratio] by Automated count

108

938

1.15

0.75

3.0

2.3

13.3

13.1

1.33

108

925

(44806071)

1.64

0.75

1.1

—

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

167

1495

1.12

0.74

2.3

2.5

175.9

182.7

0.54

160

1422

(3017569) Oxygen content in Arterial blood

167

1.38

0.73

2.7

2.4

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

2.00

0.72

1.6

2.6

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.00

0.72

1.4

1.0

—

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.00

0.72

1.0

u/l

55.0

51.5

—

(3025315) Body weight

1.80

0.72

3.0

3.3

—

(3050794) Legionella sp Ab [Presence] in Serum

1.80

0.72

1.0

1.1

—

(4038314)

1.61

0.72

1.3

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

1.62

0.71

1.1

1.2

—

166.5

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

389

0.77

0.71

2.0

1.7

—

(1002224) Polysomnography panel

292

2696

1.09

0.71

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

444

1.22

0.70

3.1

3.4

—

(3044007) Cell count panel - Peritoneal fluid

144

0.62

0.69

1.2

2.0

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

130

1152

1.13

0.69

1.3

1.4

—

(3019174) dRVVT (LA screen)

1.67

0.68

1.3

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

722

6888

1.05

0.68

1.6

1.7

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

961

0.86

0.67

1.4

1.3

ug/l

4.8

3.8

0.28

866

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

328

0.76

0.66

1.2

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

1.54

0.65

1.0

1.4

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

1.59

0.65

1.0

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

1.57

0.65

1.5

1.1

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

812

7783

1.05

0.64

1.7

1.8

1.5

1.4

2.00

717

6971

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.72

0.64

1.0

1.1

—

(40765096) Chromosome analysis panel by Banding

128

0.62

0.63

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

1.67

0.61

1.8

1.9

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

835

0.86

0.61

1.2

—

(3023199) Leukocytes [#/volume] in Pleural fluid

471

1.19

0.60

1.5

e6/l

1830.9

2352.5

0.53

345

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.00

0.60

0.0

1.9

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

498

0.82

0.59

1.3

1.6

promille

1.0

1.4

1.07

382

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

1.56

0.58

1.2

1.5

ng/l

75.6

126.2

—

(3050129) First trimester maternal screen panel - Serum or Plasma

253

2348

1.08

0.58

1.4

—

(4212803)

1.71

0.57

1.0

1.1

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

149

1.34

0.57

1.1

1.2

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

283

1.24

0.56

1.0

ng/l

35.9

43.7

0.93

202

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

1.54

0.55

1.0

2.0

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

307

0.78

0.55

1.4

1.8

—

(3003181) Sodium [Moles/volume] in Urine

682

1.15

0.54

1.6

1.3

mmol/l

61.3

64.7

0.30

531

(40765089) Chromosome analysis panel - Blood by G-banded

239

0.75

0.54

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

1.48

0.53

5.6

7.9

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

258

1.24

0.53

1.0

1.1

u/ml

21.6

11.4

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

322

1.21

0.53

1.3

—

(40768446) Kidney Pathology biopsy report

187

1.28

0.52

1.8

1.6

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

205

1.27

0.52

1.2

1.5

mu/l

469.2

415.8

0.22

195

(3024869) Neuronal Ab [Presence] in Serum

1.43

0.52

1.0

1.1

—

(3016750) Collection duration of Urine

250

1.24

0.52

1.8

2.2

min

500.7

496.4

0.10

196

(3047189) Immunofixation for 24 hour Urine

170

1.30

0.51

1.7

1.9

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

162

1.30

0.50

1.1

1.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

408

1.18

0.49

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

167

1538

1.09

0.49

1.8

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

891

8624

1.04

0.48

2.8

2.7

ug/l

0.7

2.93

584

5173

(3010937) Rubella virus Ab [Presence] in Serum

1.52

0.48

1.1

—

(3020393) Adenovirus Ag [Presence] in Stool

1.52

0.48

1.0

1.2

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

281

1.21

0.47

1.0

ng/l

804.7

741.0

0.24

195

(3002256) Pathology report gross observation

682

6571

1.04

0.47

1.3

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

364

1.18

0.47

1.7

1.6

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

282

1.21

0.46

1.0

ng/l

269.0

314.4

0.89

205

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

473

4523

1.05

0.46

3.3

4.4

ug/l

109.4

30.2

0.88

367

3596

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.43

0.46

1.0

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

1.38

0.45

1.2

1.3

—

(3004775) Volume in Urine collected for unspecified duration

347

1.18

0.45

1.9

2.3

882.7

621.0

1.70

243

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

211

1.23

0.43

1.2

1.5

74.7

73.2

0.19

201

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

104

1.35

0.43

1.6

1.3

ug/l

2.1

408.3

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.61

0.43

1.0

5.0

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

1.56

0.42

1.8

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

220

2342

0.94

0.41

1.8

1.7

mg/l

4.8

3.5

0.64

169

1554

(3011648) Oxygen content in Venous blood

369

1.17

0.41

2.6

2.5

10.9

11.4

0.36

369

(3021855) Mononuclear cells [#/volume] in Cerebral spinal fluid

0.00

0.41

0.0

1.1

—

19.2

—

(3019396) Amylase.pancreatic [Enzymatic activity/volume] in Urine

0.00

0.41

0.0

1.0

—

198.8

—

(3019977) pH of Arterial blood

222

1.22

0.40

3.0

2.8

7.4

—

(3040661) Urea [Moles/volume] in Peritoneal dialysis fluid

0.00

0.40

0.0

6.4

—

16.3

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

4.9

—

3.1

—

(40758292) HTLV I+II Ab panel - Serum

101

0.69

0.39

1.3

1.5

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

389

0.85

0.39

1.3

1.4

nmol/l

45.1

30.9

0.91

346

(44806420)

106

0.66

0.39

2.1

2.3

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

429

1.14

0.38

1.4

e6/l

38117.3

62359.2

0.66

258

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

882

0.91

0.36

1.2

1.1

iu/ml

8.8

11136.5

0.56

218

(40768795) Lymph node Pathology biopsy report

450

0.87

0.36

1.3

1.2

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

1.43

0.35

1.0

1.3

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

140

1305

1.07

0.34

1.5

—

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.36

0.34

1.0

—

(3012441) Differential panel - Pleural fluid

405

1.14

0.34

1.3

1.5

—

(3035880) pH of Pleural fluid

200

1.20

0.33

1.5

1.3

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

251

2389

1.05

0.33

1.7

1.9

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

182

1.21

0.33

1.0

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

155

1.23

0.32

1.1

u/ml

0.1

2.1

—

(3042517) Benzodiazepines panel - Urine

1.33

0.32

1.5

2.7

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

154

1447

1.07

0.31

1.1

—

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.32

0.30

1.1

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.33

0.30

1.1

1.2

—

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

175

1.20

0.30

1.2

1.1

26.2

19.0

—

(4015189)

1.31

0.30

3.0

2.3

—

(40761539) Cells [Type] in Urine sediment by Light microscopy

111

1.26

0.30

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

180

1705

1.06

0.29

1.5

—

(3028717) Thiamine [Mass/volume] in Blood

1.25

0.29

1.1

1.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

245

2342

1.05

0.29

2.3

2.4

—

(4024509)

392

1.12

0.29

1.4

1.5

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

689

1.09

0.28

1.4

1.3

u/l

41.6

36.9

0.11

600

(3035933) Granulocytes/100 leukocytes in Blood

167

1.20

0.28

1.1

1.9

—

(3027231) Wheat IgE Ab [Units/volume] in Serum

103

1.26

0.28

1.1

1.0

—

2.4

—

(4133840)

149

1.21

0.27

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

171

1623

1.06

0.27

3.3

3.8

u/ml

4126.0

3100.8

0.11

141

1421

(3041806) Other cells [#/volume] in Blood by Manual count

252

1.15

0.27

1.6

1.5

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

356

1.12

0.27

1.3

1.2

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

129

1215

1.06

0.26

1.0

1.1

u/ml

5.8

6.3

0.08

619

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

142

1344

1.06

0.25

1.1

u/ml

1.8

1.7

0.04

524

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

403

0.89

0.24

1.5

1.8

—

(3033799) Differential panel - Peritoneal fluid

148

0.81

0.24

2.0

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

115

1.22

0.23

9.3

7.6

—

(40757373) Influenza virus identified in Isolate

0.75

0.22

1.1

1.6

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

125

1.20

0.22

1.5

1.8

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.19

0.21

2.8

2.1

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.21

0.0

7.8

—

(3002079) Sodium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

118.0

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

0.00

0.21

0.0

10.5

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.21

0.0

5.0

—

(3020934) Sesame Seed IgE Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

0.5

—

(3020874) Milk IgE Ab [Units/volume] in Serum

402

1.10

0.20

1.1

1.0

u/ml

0.2

2.3

1.10

101

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

108

1.20

0.20

1.1

—

(3012898) Urea [Moles/volume] in Urine

1.22

0.20

1.2

1.6

mmol/l

249.2

179.0

—

(3026250) Tacrolimus [Mass/volume] in Blood

229

0.87

0.20

42.9

34.3

ug/l

6.8

7.6

0.99

212

(3024928) Oxygen saturation in Venous blood

937

1.06

0.19

4.2

3.4

—

(3008116) Ketones [Moles/volume] in Urine by Test strip

1.21

0.19

1.3

1.4

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.21

0.19

1.1

1.2

—

(40768793) Breast Pathology biopsy report

111

1167

0.95

0.19

1.3

—

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

122

0.82

0.19

1.2

—

(3001556) Androgen free Index in Serum or Plasma

1.23

0.18

1.2

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

100

1.20

0.18

1.2

1.1

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.21

0.17

2.6

3.1

u/l

5666.3

859.7

0.57

(3038177) Helicobacter pylori Ab [Presence] in Serum

1040

0.95

0.17

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

109

1040

1.05

0.17

5.0

3.6

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

184

0.87

0.17

1.1

1.2

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.76

0.17

1.4

1.5

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

359

1.09

0.16

1.1

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.18

0.16

1.1

1.0

—

(4198724)

340

1.09

0.16

2.4

3.3

—

(3035285) Chloride [Moles/volume] in Venous blood

486

1.07

0.16

2.7

2.2

mmol/l

105.9

105.3

0.44

477

(3041354) Potassium [Moles/volume] in Venous blood

486

1.07

0.16

2.7

2.2

mmol/l

4.1

4.0

0.59

477

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

497

1.07

0.15

1.4

mmol/l

12.1

11.5

—

117

(3051651) Icteric interference index of Serum or Plasma

294

1.09

0.14

2.8

3.7

—

(40768806) Pleura Pathology biopsy report

430

0.93

0.14

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

832

1.05

0.13

1.1

1.0

u/ml

0.0

0.8

1.76

173

(3028707) Methadone [Presence] in Urine by Screen method

131

1265

1.04

0.13

3.1

3.3

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

908

0.96

0.13

1.6

—

(40768800) Prostate Pathology biopsy report

816

0.96

0.13

1.2

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

107

0.84

0.13

2.1

2.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

687

1.05

0.12

2.3

2.6

—

(3043410) Blood group antigens tested for on Red Blood Cells

127

0.87

0.12

2.0

1.8

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

179

0.89

0.12

1.0

1.1

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

110

1062

1.04

0.12

1.5

1.4

nmol/l

0.4

0.63

842

(3010726) Horse dander IgE Ab [Units/volume] in Serum

112

1157

0.97

0.11

1.1

u/ml

1.7

2.0

0.07

280

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

250

0.92

0.11

1.2

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

219

0.91

0.11

1.2

1.1

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

260

1.08

0.10

1.5

nmol/l

1.4

1.2

0.17

200

(3033705) Calcium.ionized [Moles/volume] in Venous blood

475

1.05

0.10

2.7

2.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

228

0.92

0.10

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

103

1002

1.03

0.08

1.1

u/ml

1.6

4.2

3.56

380

(3023430) Cat dander IgE Ab [Units/volume] in Serum

933

1.03

0.08

1.0

1.1

u/ml

2.8

4.3

0.65

361

(3008401) Mugwort IgE Ab [Units/volume] in Serum

120

1171

1.03

0.08

1.0

1.1

u/ml

0.6

1.3

1.90

482

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

1.08

0.08

1.3

1.1

pmol/l

—

6.4

—

(3045142) Bone marrow Pathology biopsy report

470

0.96

0.08

1.3

1.4

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

108

1.11

0.07

9.8

7.8

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.03

0.07

3.9

5.6

—

(3017509) Phencyclidine [Presence] in Urine

1.03

0.07

1.2

1.7

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

102

1044

0.98

0.06

3.0

mg/l

22.8

26.5

0.51

629

(3024471) HLA-A [Type]

177

1.07

0.06

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

103

0.87

0.06

1.1

1.4

g/l

33.0

23.7

—

(3025130) Human papilloma virus identified in Specimen

850

0.98

0.06

1.9

1.8

—

(3000764) Benzodiazepines [Presence] in Urine

309

3058

1.01

0.05

2.2

2.3

—

(3002619) Bacteria identified in Specimen by Culture

1.11

0.05

1.0

1.2

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

1.11

0.05

5.0

7.7

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

1.08

0.04

2.4

2.8

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

130

1.08

0.04

2.4

2.8

—

(3011288) Drugs identified in Urine by Screen method

201

2031

0.99

0.04

3.4

—

(3042733) HLA Ab [Presence] in Serum

170

0.94

0.04

4.4

5.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

533

0.98

0.04

1.7

1.6

mmol/l

8.0

7.7

0.47

332

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

210

0.95

0.03

6.8

9.4

u/ml

2292.0

9402.3

—

(3027008) Opiates [Presence] in Urine

310

3078

1.01

0.03

2.1

2.2

—

(4094501)

136

1375

0.99

0.03

1.1

—

(4035726)

428

4260

1.01

0.02

1.3

1.4

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

184

1826

1.01

0.02

1.7

1.8

—

(3028300) Cannabinoids [Presence] in Urine

310

3085

1.01

0.02

2.2

2.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

358

0.98

0.01

1.7

3.2

—

(3045788) Cell count panel - Pleural fluid

373

1.02

0.01

1.4

1.5

—

(3002523) Influenza virus A Ag [Presence] in Specimen

110

1108

0.99

0.01

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

633

6319

1.00

0.01

1.8

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

106

0.94

0.01

1.3

1.1

—

(3016879) Cocaine [Presence] in Urine

285

2843

1.00

0.00

2.2

2.4

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

112

0.98

0.00

1.0

1.1

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

112

0.98

0.00

1.0

1.1

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

112

0.98

0.00

1.0

1.1

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

132

0.98

0.00

1.3

2.1

umol/l

12.1

16.1

0.79

132

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

138

1.01

0.00

1.4

1.5

47.7

64.6

—

122

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

105

1.05

0.00

2.2

2.5

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

115

1.04

0.00

3.0

2.7

ng/l

127.5

140.3

—

(3024932) HLA-DR beta [Type]

175

0.97

0.00

1.2

1.1

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

412

1.00

0.00

1.1

1.0

u/ml

0.7

1.1

—

(4146454)

404

0.99

0.00

2.7

2.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

646

1.01

0.00

1.1

1.3

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

101

1014

1.00

0.00

1.8

2.3

nmol/l

0.8

0.45

854

(3037556) Urate [Mass/volume] in Serum or Plasma

109

1.01

0.00

1.1

1.4

—

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

0.00

0.0

1.2

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

0.93

0.00

1.2

1.1

—

(36303858) Crystals [Presence] in Urine

0.00

0.0

1.1

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.96

0.00

1.1

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.98

0.00

2.8

1.9

—

(3032995) BK virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

0.0

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

1.00

0.00

1.0

1.2

—

(3052912) Proteinase 3 IgG Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.98

0.00

1.1

1.0

—

(3016976) Cortisol [Moles/volume] in Serum or Plasma --baseline

0.00

0.0

1.0

—

285.0

—

(3003740) Influenza virus B Ag [Presence] in Specimen

111

1110

1.00

0.00

1.1

—

(3012932) Hazelnut IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

7.8

—

(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma

0.90

0.00

2.8

2.3

pmol/l

23.7

66.8

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.91

0.00

13.3

7.0

—

(3027944) Amphetamines [Presence] in Urine

304

3040

1.00

0.00

2.1

2.2

—

(3008536) Aspergillus sp Ab [Presence] in Serum

0.96

0.00

3.6

2.7

—

Mortality – FinRegistry

↥

Association

Association between endpoint SPONDYLOPATHY_FG and mortality.

Females

Parameter	HR [95% CI]	p-value
SPONDYLOPATHY_FG	1.297 [1.16, 1.46]	< 0.001
Birth year	0.994 [0.99, 1.0]	0.145

During the follow-up period (1.1.1998 — 31.12.2019), 923 out of 14784 females with SPONDYLOPATHY_FG died.

Males

Parameter	HR [95% CI]	p-value
SPONDYLOPATHY_FG	1.276 [1.15, 1.41]	< 0.001
Birth year	0.985 [0.98, 1.0]	0.004

During the follow-up period (1.1.1998 — 31.12.2019), 1385 out of 13601 males with SPONDYLOPATHY_FG died.

Mortality risk

Mortality risk for people of age

years, who have SPONDYLOPATHY_FG.

N-year risk	Females	Males
1	0.123%	0.224%
5	0.729%	1.405%
10	2.033%	3.6%
15	3.661%	6.856%
20	6.263%	11.253%

Relationships between endpoints

↥

Index endpoint: SPONDYLOPATHY_FG – Spondylopathies (FG)

GWS hits: 27

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Spondylopathies (FG)

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints